Sources: 44NIH Clinical Center, 4ClinicalTrials, 32LifeMap Discovery®, 15FDA, 41NCI, 13DrugBank, 65UMLS, 43NDF-RT, 26HMDB, 9DGIdb, 53PharmGKB, 30IUPHAR, 47Novoseek, 1BitterDBSee all MalaCards sources |
FDA approved drugs:
| id |
|
Drug Name |
Active Ingredient(s)15 |
Company |
Approval Date |
| 1 |
|
Imbruvica15 41 |
IBRUTINIB |
Pharmacyclics |
November of 2013/ February 2014 |
Disease/s that Drug Treats:mantle cell lymphoma/chronic lymphocytic leukemia
Indications and Usage:15 IMBRUVICA is a kinase inhibitor indicated for the treatment of patients with: Mantle cell lymphoma (MCL) who have received at least one priortherapy (1.1).Accelerated approval was granted for this indication based on overallresponse rate. Continued approval for this indication may be contingentupon verification of clinical benefit in confirmatory trials. Chronic lymphocytic leukemia (CLL) who have received at least oneprior therapy (1.2). Chronic lymphocytic leukemia with 17p deletion (1.3). Waldenströmâs macroglobulinemia (WM) (1.4).
DrugBank Targets:13 1. Tyrosine-protein kinase BTK
Mechanism of Action:15
Target: Bruton's tyrosine kinase (Btk)
Action: selective inhibitor
FDA: Ibrutinib is a small-molecule inhibitor of BTK. Ibrutinib forms a covalent bond with a cysteineresidue in the BTK active site, leading to inhibition of BTK enzymatic activity. BTK is asignaling molecule of the B-cell antigen receptor (BCR) and cytokine receptor pathways. BTKâsrole in signaling through the B-cell surface receptors results in activation of pathways necessaryfor B-cell trafficking, chemotaxis, and adhesion. Nonclinical studies show that ibrutinib inhibitsmalignant B-cell proliferation and survival in vivo as well as cell migration and substrateadhesion in vitro.
|
| 2 |
|
Revlimid15 41 |
LENALIDOMIDE |
Celgene |
June 2013 |
Disease/s that Drug Treats:mantle cell lymphoma
Indications and Usage:15 REVLIMID is a thalidomide analogue indicated for the treatment of patientswith: Multiple myeloma (MM), in combination with dexamethasone (1.1). Transfusion-dependent anemia due to low- or intermediate-1-riskmyelodysplastic syndromes (MDS) associated with a deletion 5qabnormality with or without additional cytogenetic abnormalities (1.2). Mantle cell lymphoma (MCL) whose disease has relapsed or progressedafter two prior therapies, one of which included bortezomib (1.3).Limitations of Use: REVLIMID is not indicated and is not recommended for the treatmentof patients with chronic lymphocytic leukemia (CLL) outside ofcontrolled clinical trials (1.4).
DrugBank Targets:13 1. Protein cereblon;2. Tumor necrosis factor ligand superfamily member 11;3. Cadherin-5;4. Prostaglandin G/H synthase 2
Mechanism of Action:15
Target: T cells and natural killer cells/ pro-inflammatory cytokines by monocytes
Action: activator/inhibitor
FDA: Lenalidomide is an analogue of thalidomide with immunomodulatory, antiangiogenic, and antineoplastic properties. Lenalidomide inhibitsproliferation and induces apoptosis of certain hematopoietic tumor cells including multiple myeloma, mantle cell lymphoma, and del (5q)myelodysplastic syndromes in vitro. Lenalidomide causes a delay in tumor growth in some in vivo nonclinical hematopoietic tumor modelsincluding multiple myeloma. Immunomodulatory properties of lenalidomide include activation of T cells and natural killer (NK) cells, increasednumbers of NKT cells, and inhibition of pro-inflammatory cytokines (e.g., TNF-α and IL-6) by monocytes. In multiple myeloma cells, thecombination of lenalidomide and dexamethasone synergizes the inhibition of cell proliferation and the induction of apoptosis.
|
| 3 |
|
Velcade15 41 |
BORTEZOMIB |
Millennium Pharmaceuticals |
May 2003 |
Disease/s that Drug Treats:Multiple Myeloma
Indications and Usage:15 VELCADE is a proteasome inhibitor indicated for: treatment of patients with multiple myeloma (1.1) treatment of patients with mantle cell lymphoma (1.2)
DrugBank Targets:13 1. 26S proteasome non-ATPase regulatory subunit 2;2. 26S proteasome non-ATPase regulatory subunit 1;3. Proteasome subunit beta type-1;4. Proteasome subunit beta type-5;5. Proteasome subunit beta type-2
Mechanism of Action:15
Target: 26S proteasome
Action: reversible inhibitor of chymotrypsin-like activity
FDA: Bortezomib is a reversible inhibitor of the chymotrypsin-like activity of the 26S proteasome in mammaliancells. The 26S proteasome is a large protein complex that degrades ubiquitinated proteins. The ubiquitinproteasomepathway plays an essential role in regulating the intracellular concentration of specific proteins,thereby maintaining homeostasis within cells. Inhibition of the 26S proteasome prevents this targetedproteolysis, which can affect multiple signaling cascades within the cell. This disruption of normal homeostaticmechanisms can lead to cell death. Experiments have demonstrated that bortezomib is cytotoxic to a variety ofcancer cell types in vitro. Bortezomib causes a delay in tumor growth in vivo in nonclinical tumor models,including multiple myeloma.
|
Drugs for Mantle Cell Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 463)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Miconazole | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 3026 | 22916-47-8 | 4189 | (+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole 1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole 1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole 1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole 1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole 1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole 1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole 1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole 22832-87-7 (NITRATE) 22916-47-8 75319-47-0 AB00053500 AC1L1HM1 AKOS001574474 Aflorix(nitrate) Albistat(nitrate) Andergin(nitrate) BPBio1_000279 BRD-A82396632-001-03-0 BRD-A82396632-008-02-7 BRN 0965511 BSPBio_000253 BSPBio_002033 CCRIS 7924 CHEBI:6923 CHEMBL91 CID4189 CPD-4501 Conofite(nitrate) D00416 DB01110 Dactarin Daktarin IV Daktarin iv Desenex DivK1c_000156 EINECS 245-324-5 Epi-Monistat(nitrate) Femizol-M Florid(nitrate) Gyno-Daktar(nitrate) HMS1568M15 HMS2090B21 I14-14342 IDI1_000156 Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI) KBio1_000156 KBio2_001445 KBio2_004013 KBio2_006581 KBio3_001533 KBioGR_000581 KBioSS_001445 LS-78378 Lotrimin AF(nitrate) MCZ MJR 1762 MLS002222203 Makesense Micantin (nitrate) Micatin | Miconasil Nitrate Miconazol Miconazol [INN-Spanish] Miconazole Miconazole (JP15/USP/INN) Miconazole 3 Miconazole 3 Combination Pack Miconazole 7 Combination Pack Miconazole [USAN:BAN:INN:JAN] Miconazole nitrate salt Miconazole-7 Miconazolo Miconazolo [DCIT] Miconazolum Miconazolum [INN-Latin] Micozole Minostate MolPort-002-557-553 Monazole 7 Monista (nitrate) Monistat Monistat (TN) Monistat 1 Combination Pack Monistat 3 Dual-Pak Monistat 3 Vaginal Ovules Monistat 5 Tampon Monistat 7 Dual-Pak Monistat 7 Vaginal Suppositories Monistat Dual- PAK Monistat IV Monistat iv (TN) Monistat iv (tn) Monistat-Derm NCI60_001353 NCI60_001380 NINDS_000156 NSC 170986 NSC169434 NSC170986 Novo-Miconazole Vaginal Ovules Oprea1_091955 Oravig Prestwick0_000067 Prestwick1_000067 Prestwick2_000067 Prestwick3_000067 Prestwick_335 R 18134 R-14,889 Rash Relief Antifungal SMR001307249 SPBio_000976 SPBio_002174 STK834405 STOCK1S-93556 Spectrum2_001048 Spectrum3_000507 Spectrum4_000061 Spectrum5_001297 Spectrum_000965 UNII-7NNO0D7S5M Vusion Zimycan imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI) miconazole |
| | 2 | | Sirolimus | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 1797 | 53123-88-9 | 5284616, 6436030, 46835353 | (-)-Rapamycin (-)-rapamycin 1fkb 1pbk 23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine 23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29 3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone 53123-88-9 A422989, NSC226080 AC-722 AC1L1JH9 AC1L7MJ9 AC1L9ZMV AY 22989 AY-22989 AY22989 Ambotz53123-88-9 Antibiotic AY 22989 BIDD:PXR0165 Bio1_000293 Bio1_000782 Bio1_001271 Bio2_000375 Bio2_000855 BiomolKI2_000084 C07909 C51H79NO13 CBiol_002007 CCRIS 9024 CHEBI:100923 CHEBI:9168 CHEMBL413 CID10213190 CID10795871 CID11949238 CID11959112 CID313006 CID478951 CID5040 CID5284616 CID5358081 CID5374464 CID5460439 CID5497196 CID5924240 CID6436030 CID6610270 CID6610346 CID6711160 CID6713081 CID9833581 CID9854379 CID9854380 CID9962926 CID9962928 D00753 DB00877 DE-109 DivK1c_006936 | FT-0082351 HMS2089A21 HSDB 7284 KBio1_001880 KBio2_000410 KBio2_002978 KBio2_005546 KBio3_000779 KBio3_000780 KBioGR_000410 KBioSS_000410 LCP-Siro LMPK06000003 LS-143290 MLS000028373 MS-R001 MolMap_000043 MolPort-003-959-433 NCGC00021305-05 NCI60_001851 NCIMech_000355 NSC 226080 NSC226080 Perceiva QTL1_000069 R0395_SIAL R0395_SIGMA RAP RAPA RPM Rapammune Rapamune Rapamune (TN) Rapamycin Rapamycin (TN) Rapamycin C-7, analog 4 Rapamycin Immunosuppressant Drug Rapamycin from Streptomyces hygroscopicus S1039_Selleck SIIA 9268A SILA 9268A SILA9268A SMP1_000255 SMR000058564 Sirolimus Sirolimus (RAPAMUNE) Sirolimus (USAN/INN) Sirolimus [USAN:BAN:INN] Sirolimus, Rapamune,Rapamycin SpecPlus_000840 UNII-W36ZG6FT64 UNM-0000358684 WY-090217 Wy 090217 heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy nchembio.100-comp4 nchembio.2007.42-comp2 nchembio.79-comp1 nchembio762-comp1 nchembio883-comp3 rapamycin sirolimus |
| | 3 | | Thiotepa | approved | Phase 4, Phase 2, Phase 3, Phase 1 | 205 | 52-24-4 | 5453 | | | 4 | | Everolimus | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1797 | 159351-69-6 | 6442177 | (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy 07741_FLUKA 159351-69-6 40-O-(2-hydroxyethyl)-rapamycin 42-O-(2-Hydroxyethyl)rapamycin Afinitor Afinitor Disperz CERTICAN(R) CHEMBL1201755 Certican D02714 DB01590 | Everolimus Everolimus (JAN/USAN/INN) Everolimus [USAN] LS-143292 MolPort-003-847-342 MolPort-003-925-588 NCGC00167512-01 NVP-RAD-001 RAD 001 RAD-001 RAD-001C RAD001 RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus S1120_Selleck SDZ-RAD UNII-9HW64Q8G6G VOTUBIA Zortress everolimus |
| | 5 | | Cyclophosphamide | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1, Phase 0 | 2643 | 50-18-0, 6055-19-2 | 2907 | (+-)-Cyclophosphamide (-)-Cyclophosphamide (RS)-Cyclophosphamide 1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine 1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin 2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide 4-Hydroxy-cyclophosphan-mamophosphatide 50-18-0 60007-95-6 6055-19-2 (monohydrate) 75526-90-8 AC1L1EQQ AI3-26198 ASTA ASTA B518 Asta B 518 B 518 B-518 BRN 0011744 BSPBio_002099 Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester C 0768 C07888 C7H15Cl2N2O2P CB 4564 CB-4564 CCRIS 188 CHEBI:4027 CHEMBL32520 CHEMBL88 CID2907 CP CPA CTX CY Ciclofosfamida Ciclofosfamida [INN-Spanish] Ciclofosfamide Ciclophosphamide Ciclophosphamide [INN] Clafen Claphene Cycloblastin Cyclophosphamid Cyclophosphamide Cyclophosphamide (INN) Cyclophosphamide (TN) Cyclophosphamide (anhydrous form) Cyclophosphamide (anhydrous) Cyclophosphamide Monohydrate Cyclophosphamide Sterile Cyclophosphamide anhydrous Cyclophosphamide, (+-)-Isomer Cyclophosphamides Cyclophosphamidum Cyclophosphamidum [INN-Latin] Cyclophosphan Cyclophosphane Cyclophosphanum Cyclophosphoramide Cyclostin Cyklofosfamid Cyklofosfamid [Czech] Cytophosphan Cytophosphane Cytoxan Cytoxan (TN) Cytoxan Lyoph D,L-Cyclophosphamide D07760 DB00531 | DivK1c_000246 EINECS 200-015-4 EU-0100238 Endoxan Endoxan R Endoxan-Asta Endoxana Endoxanal Endoxane Enduxan Genoxal HMS2090A12 HSDB 3047 Hexadrin IDI1_000246 KBio1_000246 KBio2_001338 KBio2_003906 KBio2_006474 KBio3_001319 KBioGR_000888 KBioSS_001338 LS-1302 LS-99787 Ledoxina Lopac-C-0768 Lopac0_000238 Lyophilized Cytoxan Mitoxan MolPort-001-783-420 N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide NCGC00015209-01 NCGC00015209-03 NCGC00015209-06 NCGC00091741-02 NCGC00091741-03 NCI-C04900 NCI60_002097 NINDS_000246 NSC 26271 NSC-26271 NSC26271 NSC273033 NSC273034 Neosar Occupation, cyclophosphamide exposure Procytox RCRA waste no. U058 Rcra Waste Number U058 Rcra waste number U058 Revimmune S1217_Selleck SK 20501 SPBio_001071 STK177249 STOCK2S-91217 Semdoxan Sendoxan Senduxan Spectrum2_001146 Spectrum3_000370 Spectrum4_000304 Spectrum5_000795 Spectrum_000858 UNII-6UXW23996M WLN: T6MPOTJ BO BN2G2G Zyklophosphamid Zyklophosphamid [German] bis(2-Chloroethyl)phosphami de cyclic propanolamide bis(2-Chloroethyl)phosphamide cyclic propanolamide ester cyclophosphamide | |
| | 6 | | Immunologic Factors | | Phase 4, Phase 3, Phase 2, Phase 1, Phase 0 | 18483 | | | | 7 | | lenograstim | | Phase 4, Phase 3, Phase 2, Phase 1, Phase 0 | 1134 | | | | 8 | | Immunosuppressive Agents | | Phase 4, Phase 3, Phase 2, Phase 1, Phase 0 | 10422 | | | | 9 | | Anti-Infective Agents | | Phase 4, Phase 3, Phase 2, Phase 1, Phase 0 | 17220 | | | | 10 | | Antilymphocyte Serum | | Phase 4, Phase 2, Phase 3, Phase 1 | 388 | | | | 11 | | Antibiotics, Antitubercular | | Phase 4, Phase 3, Phase 2, Phase 1 | 5971 | | | | 12 | | Anti-Bacterial Agents | | Phase 4, Phase 3, Phase 2, Phase 1 | 9140 | | | | 13 | | Antifungal Agents | | Phase 4, Phase 3, Phase 2, Phase 1 | 3015 | | | | 14 | | Fluconazole | approved | Phase 3 | 171 | 86386-73-4 | 3365 | 2,4-Difluoro-alpha,alpha-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol 2,4-difluoro-,1-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol 2-(2,4-DIFLUOROPHENYL)-1,3-DI(1H-1,2,4-TRIAZOL-1-YL)PROPAN-2-OL 2-(2,4-DIFLUOROPHENYL)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol 2-(2,4-Difluoro-phenyl)-1,3-bis-[1,2,4]triazol-1-yl-propan-2-ol 2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)-2-propanol 2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol 2-(2,4-Difluorophenyl)-1,3-di-1H-1,2,4-triazol-1-ylpropan-2-ol 2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol 86386-73-4 AC-428 AC1L1FRQ AC1Q77FV AKOS000280854 AbZ Brand of Fluconazole Afungil Alflucoz Aliud Brand of Fluconazole Alpharma Brand of Fluconazole Apo Fluconazole Apo-Fluconazole Apotex Brand of Fluconazole Armstrong Brand of Fluconazole BIDD:GT0799 BRD-K05977355-001-02-6 BSPBio_003504 Baten Beagyne Bio-0041 Biocanol Biozole Biozolene C13H12F2N6O CCRIS 7211 CHEBI:46081 CHEMBL106 CID3365 CPD000471882 Canesoral Canzol Chemia Brand of Fluconazole Cryptal D00322 D015725 DB00196 DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER DIFLUCAN IN SODIUM CHLORIDE 0.9% DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER DRG-0005 Diflazon Diflucan Diflucan (TN) Diflucan, Trican, Alfumet, Fluconazole Dimycon DivK1c_001030 Effik Brand of Fluconazole Elazor F0677 F8929_SIGMA FCZ FLCZ Fluc Hexal Flucazol FlucoLich Flucobeta Fluconazol Fluconazol AL Fluconazol AbZ Fluconazol Isis Fluconazol Stada Fluconazol [Spanish] Fluconazol ratiopharm Fluconazol von ct Fluconazol-Isis Fluconazol-ratiopharm Fluconazole Fluconazole & Bovine Lactoferrin Fluconazole & Human recombinant granulocyte colony stimulating factor Fluconazole & MC-510,011 Fluconazole & hGCSF Fluconazole (JAN/USAN/INN) Fluconazole [USAN:INN:BAN:JAN] Fluconazole in combination with MGCD290 Fluconazole in dextrose 5% in plastic container Fluconazole in sodium chloride 0.9% Fluconazole in sodium chloride 0.9% in plastic container Fluconazolum Fluconazolum [Latin] Flucostat | Flucytosine & Nyotran Flucytosine & Nyotran(Liposomal Nystatin) Flukezol Flunazul Flunizol Fluzone Forcan Fuconal Fungata GL663142 & Fluconazole HMS1922O10 HMS2090I20 HMS2093M21 HMS503M21 HSDB 7420 Hexal Brand of Fluconazole I06-0069 IDI1_001030 KBio1_001030 KBio2_002134 KBio2_004702 KBio2_007270 KBio3_003009 KBioGR_000360 KBioSS_002134 KS-1059 LS-1858 Lavisa Lesvi Brand of Fluconazole Lichtenstein Brand of Fluconazole Loitin MLS001066394 MLS001165780 MLS001195645 MLS001304713 MLS001306492 Mack Brand of Fluconazole MolPort-000-883-859 MolPort-002-885-825 Monicure Mutum NCGC00095089-01 NCGC00095089-02 NCGC00095089-04 NCGC00095089-05 NINDS_001030 Neofomiral Oxifugol Oxifungol Pfizer Brand of Fluconazole Pfleger Brand of Fluconazole Pritenzol S1331_Selleck SAM002589905 SAT Brand of Fluconazole SMR000471882 SPBio_001613 SPECTRUM1503975 STK619301 Silanes Brand of Fluconazole Solacap Spectrum2_001607 Spectrum3_001912 Spectrum4_000090 Spectrum5_001277 Spectrum_001654 Stada Brand of Fluconazole Syscan TL8005609 TPF Triflucan UK 49858 UK-49858 UK49858 UNII-8VZV102JFY Vita Brand of Fluconazole XMP.284 & Fluconazole XMP.366 & Fluconazole XMP.391 & Fluconazole ZINC00004009 Zemyc Zoltec Zonal betapharm Brand of Fluconazole ct Arzneimittel Brand of Fluconazole ct-Arzneimittel Brand of Fluconazole fluconazole nchembio.100-comp3 nchembio.65-comp15 ratiopharm Brand of Fluconazole | |
| | 15 | | Captopril | approved | Phase 3 | 29 | 62571-86-2 | 44093 | (2S)-1-(3-Mercapto-2-methylpropionyl)-L-proline (2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid (2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid (S)-1-(3-Mercapto-2-methyl-1-oxo-propyl)-L-proline (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline 1-((2S)-3-Mercapto-2-methylpropionyl)-L-proline 1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline 1-(D-3-Mercapto-2-methyl-1-oxopropyl)-L-proline (S,S) 1-[(2S)-2-methyl-3-sulfanylpropanoyl]-L-proline 1j37 3-Mercapto-2-methylpropionyl-proline 62571-86-2 AC-12047 AC1L2B4L AC1Q29GZ AC1Q5R48 Acediur Aceplus Acepress Acepril Alopresin Apopril Apopril (TN) Asisten BB_NC-2104 BIM-0050290.0001 BPBio1_000063 BRD-K54529596-001-04-0 BSPBio_000057 BSPBio_002976 C 4042 C4042_SIAL C4042_SIGMA C8856_SIAL C9H15NO3S CHEBI:3380 CHEMBL1560 CHEMBL82 CID44093 CP CPD0-2067 CPD000059061 Capoten Capoten (TN) Captolane Captopril Captopril (JP15/USP/INN) Captopril [USAN:INN:BAN:JAN] Captoprilum Captoprilum [INN-Latin] Captopryl Captoril Captril Cesplon D-2-Methyl-3-mercaptopropanoyl-L-proline D-3-Mercapto-2-methylpropanoyl-L-proline D-3-Mercapto-2-methylpropionylproline D00251 DB01197 Dilabar DivK1c_000208 EINECS 263-607-1 EU-0100302 FT-0082749 Garranil Garranil (discontinued) HMS1921C12 | HMS2089P19 HMS2092I12 HMS500K10 HSDB 6527 Hipertil Hypertil IDI1_000208 Isopresol KBio1_000208 KBio2_001168 KBio2_003736 KBio2_006304 KBio3_002196 KBioGR_001321 KBioSS_001168 L-Captopril LS-137465 Lopac-C-4042 Lopac0_000302 Lopirin Lopirin [Switzerland] Lopril MCO MLS000069484 MLS001076488 MolPort-001-794-639 N-[(S)-3-Mercapto-2-methylpropionyl]-L-proline NCGC00015235-01 NCGC00015235-02 NCGC00023654-03 NCGC00023654-04 NCGC00023654-05 NCGC00023654-06 NCGC00023654-07 NCGC00023654-08 NCGC00023654-09 NCGC00023654-10 NINDS_000208 Prestwick3_000019 Prestwick_103 SA 333 SAM002564201 SMP1_000056 SMR000059061 SPBio_001022 SPECTRUM1500682 SQ 14,225 SQ 14225 SQ-14,225 SQ-14,534 SQ-14225 SQ-14534 ST079562 STK802012 Spectrum2_001211 Spectrum3_001388 Spectrum4_000811 Spectrum5_001587 Spectrum_000688 Tenosbon Tensiomin Tensobon Tensoprel UNII-9G64RSX1XD UPCMLD-DP003 UPCMLD-DP003:001 X8Z [2S]-1-[3-Mercapto-2-methylpropionyl]-L-proline captopril |
| | 16 | | Ribavirin | approved | Phase 3 | 948 | 36791-04-5 | 37542 | 1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide 1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide 36791-04-5 437710-49-1 66510-90-5 AA-504/07617051 AB00430481 AC1L1XXZ AC1Q1IDC AC1Q4ZGS AKOS001715163 BB_NC-0567 BPBio1_001195 BRN 0892462 BSPBio_001085 BSPBio_003352 C-Virin CHEMBL1643 CID37542 Copegus Copegus (TN) Cotronak D00423 DB00811 DRG-0028 DivK1c_000782 Drug: Ribavirin EU-0101063 FT-0082885 HMS2090L15 HMS2094O09 HMS502H04 HSDB 6513 ICN-1229 IDI1_000782 Ibavyr KBio1_000782 KBio2_002328 KBio2_004896 KBio2_007464 KBio3_002854 KBioGR_001804 KBioSS_002331 KS-1104 LS-1241 Lopac0_001063 MLS000028486 MLS002222317 Moderiba MolPort-002-507-104 MolPort-002-885-856 NCGC00090726-01 NCGC00090726-03 NCGC00090726-04 NCGC00090726-05 NCGC00090726-06 NCGC00090726-07 NINDS_000782 | NSC 163039 NSC163039 Prestwick3_000993 R 9644 R-964 R9644_SIGMA RBV RG-964 RIBAV RTC RTCA RTP Ravanex Rebetol Rebetol (TN) Rebetron Rebretron Ribacine Ribamide Ribamidil Ribamidyl Ribasphere Ribasphere (TN) Ribasphere Ribapak Ribav Ribavirin Ribavirin (JAN/USP/INN) Ribavirin Capsules Ribavirin Triphosphate Ribavirin [USAN:INN] Ribavirin-TP Ribavirina Ribavirina [INN-Spanish] Ribavirine Ribavirine [INN-French] Ribavirinum Ribavirinum [INN-Latin] Ribovirin Ro 20-9963/000 Ro-20-9963 S2504_Selleck SCH 18908 SMP1_000261 SMR000058315 SPECTRUM1503938 SR-01000076112-3 Spectrum3_001876 Spectrum4_001252 Spectrum5_002075 Spectrum_001826 Tribavirin UNII-49717AWG6K Varazid Vilona Viramid Viramide Virazid Virazide Virazole Virazole (Ribavirin) Inhalation Solution Virazole (TN) Virazole 5'-triphosphate ZINC01035331 ribavirin |
| | 17 | | Itraconazole | approved, investigational | Phase 3 | 134 | 84625-61-6 | 55283 | (+-)-1-sec-Butyl-4-(p-(4-(p-(((2R*,4S*)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl)-delta(sup 2)-1,2,4-triazolin-5-one (+/-)-1-[( R *)- sec -butyl]-4-[ p -[4-[ p -[[(2 R *,4 S *)-2-(2,4-dichlorophenyl)-2-(1 H -1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-(DELTA) 2 1,2,4-triazolin-5-one mixture with (+/-)-1-[( R *)- sec -butyl]-4-[ p -[4- [ p -[[(2 S *,4 R *)-2-(2,4-dichlorophenyl)-2-(1 H -1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl] phenyl]-(DELTA) 2 -1,2,4-triazolin-5-one (1)-cis-4-(4-(4-(4-((2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-2,4-dihydro-2-sec-butyl-3H-1,2,4-triazol-3-one 2-(butan-2-yl)-4-{4-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one 2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one 2-butan-2-yl-4-[4-[4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one 3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-pipera-zinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl) 4-(4-{4-[4-({[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl}oxy)phenyl]piperazin-1-yl}phenyl)-2-(1-methylpropyl)-2,4-dihydro-3H-1,2,4-triazol-3-one 84604-65-9 84625-61-6 AC-542 AC1L1GQ5 AC1L1IRU AC1OCEL7 AC1Q6EZ3 AKOS000280875 Ambap84625-61-6 BIDD:GT0796 BRN 6042047 C35H38Cl2N8O4 CHEBI:6076 CHEMBL22587 CHEMBL882 CID3793 CID55283 CID6917738 CID9961741 CPD000058959 Canadiol D00350 DB01167 EINECS 283-347-2 FT-0082511 HMS2051K14 HMS2090M20 Hyphanox I01-1043 I0732 ITC ITCZ ITZ Intraconazole | Itraconazol Itraconazol [Spanish] Itraconazole Itraconazole & Bovine Lactoferrin Itraconazole & Nyotran Itraconazole & Nyotran(Liposomal Nystatin) Itraconazole (JAN/USAN) Itraconazole [USAN:BAN:INN:JAN] Itraconazole oral solution Itraconazolum Itraconazolum [Latin] Itrizole Itrizole (TN) Itrizole (tn) LS-1843 MLS000028582 MLS000759472 MLS000863291 MLS001148245 MolPort-000-883-864 MolPort-003-848-295 NCGC00089812-03 Onmel Oriconazole Oriconazole, R51211, Sporanox Orungal Prokanazol R 51211 R-51211 S2476_Selleck SAM001246679 SMR000058959 Sempera Spherazole Sporal Sporanos Sporanox Sporanox (TN) Sporanox (tn) Sporonox TL8005525 Triasporn UNII-304NUG5GF4 cis-Itraconazole itraconazole |
| | 18 | | Morphine | approved, investigational | Phase 3 | 855 | 57-27-2 | 5288826 | (-)(5.alpha.,6.alpha.)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol (-)-Heroin hydrochloride (-)-Morphine (-)Morphine sulfate (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol (5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol (5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol (5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol (7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL (7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol (−)-morphine 17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol 4,5alpha-Epoxy-17-methyl-7-morphinen-3,6alpha-diol 4-methyl-(13R,14S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol 47106-99-0 57-27-2 6211-15-0 (sulfate (2:1) (salt) pentahydrate) 64-31-3 64-31-3 (sulfate (2:1) (salt) anhydrous) 7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol 7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol 8053-16-5 85201-37-2 Apokyn Astramorph PF Avinza BIDD:GT0147 C01516 CCRIS 5762 CHEBI:17303 CHEMBL70 CID5288826 Cube juice D-(-)-Morphine DB00295 DEA No. 9300 DepoDur Depodur Diacetylmorphine hydrochloride Diamorphine hydrochloride Dolcontin Dreamer Dulcontin Duramorph Duramorph PF Duromorph EINECS 200-320-2 Epimorph HSDB 2134 Hard stuff Heroin hydrochloride Heroine hydrochloride Hocus Infumorph | Kadian LS-91748 M-Eslon M.O.S MOI MORPHINE SULFATE MORPHINE, (5A,6A)-7,8-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINIAN-3,6-DIOL, MORPHIUM, MORPHIA, DOLCONTIN, DUROMORPH, MORPHINA, NEPENTHE MS Contin MS/L MS/S MSIR Meconium MolPort-003-849-273 Morfina Morfina [Italian] Morphia Morphin Morphin [German] Morphina Morphina [Italian] Morphine Morphine Extra-Forte Morphine Forte Morphine H.P Morphine Sulfate Morphine [BAN] Morphinism Morphinum Morphitec Morphium Morpho Moscontin Ms Contin Ms Emma NSC11441 Nepenthe O,O'-Diacetylmorphine hydrochloride OMS Concentrate Oramorph SR Ospalivina RMS RMS Uniserts Rescudose Roxanol Roxanol 100 Roxanol UD SDZ 202-250 SDZ202-250 Statex Statex Drops Statex SR UNII-76I7G6D29C Unkie l-Morphine morphine nchembio.317-comp1 nchembio.64-comp1 |
| | 19 | | Ondansetron | approved | Phase 3, Phase 2, Phase 1 | 285 | 99614-02-5 | 4595 | (RS)-1,2,3,9-Tetrahydro-9-methyl-3-(2-methylimidazol-1-ylmethyl)carbazol-4-one 1,2,3,9-Tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one 103639-04-9 (mono-hydrochloride dihydrate) 108303-49-7 116002-70-1 9-Methyl-3-(2-methyl-imidazol-1-ylmethyl)-1,2,3,9-tetrahydro-carbazol-4-one 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one 99614-01-4 (mono-hydrochloride) 99614-02-5 AB00373674 AC1L1IIM AKOS000599484 Apo-ondansetron BAS 00717177 BPBio1_001118 BRD-A19736161-001-01-8 BRD-A19736161-003-03-0 BRN 3622981 BSPBio_001016 C07325 C18H19N3O CBDivE_008994 CHEMBL46 CID4595 CPD001307702 D00456 DB00904 DESMETHYLONDANSETRON GR 38032 GR 38032X GR-38032F GR38032F HMS2090H16 I06-0687 I06-1329 L000456 | LS-172305 LS-51878 MolPort-001-944-253 NCI60_022780 Novo-ondansetron Ondansetron Ondansetron (JAN/USP/INN) Ondansetron Hydrochloride Ondansetron [USAN:INN:BAN] Ondansetron hydrochloride dihydrate Ondansetron, (+,-)-Isomer Oprea1_435466 Oprea1_852372 PHL-ondansetron PMS-ondansetron Prestwick0_001058 Prestwick1_001058 Prestwick2_001058 Prestwick3_001058 Ratio-ondansetron SAM002589958 SN-307 SPBio_002938 STK370548 STOCK4S-10990 Sandoz ondansetron TL8006071 TimTec1_001750 UNII-4AF302ESOS ZOFRAN IN PLASTIC CONTAINER Zofran Zofran ODT Zofran ODT (TN) Zofran odt Zophren Zudan Zuplenz ondansetron ondansetron (Zofran) |
| | 20 | | Palivizumab | approved, investigational | Phase 3 | 24 | 188039-54-5 | | 188039-54-5 D02737 Palivizumab Palivizumab (INN) | Palivizumab (genetical recombination) Palivizumab (genetical recombination) (JAN) Synagis Synagis (TN) anti-RSV | |
| | 21 | | Guaifenesin | approved | Phase 3, Phase 2 | 512 | 93-14-1 | 3516 | 3-(2-Methoxyphenoxy)-1,2-propanediol 3-(O-Methoxyphenoxy)-1,2-propanediol 3-(O-Methoxyphenoxy)-propanediol-1,2 3-O-Methoxyphenoxypropane 1:2-diol 7 Select Mucus Relief Actifed C Adult Tussin Adult Tussin chest congestion Aeronesin Air Power Amonidren Amonidrin Aresol Benylin-E Bidex-400 Bronchol Broncomar SF Careone Adult Tussin Careone Mucus Er Careone Mucus Relief childrens Chest Congestion Chest Congestion Relief Chest Congestion childrens Childrens Chest Congestion Childrens Chest Congestion Relief Childrens Mucinex Chest Congestion Childrens Mucinex Mini-Melts Chest Congestion Childrens Mucus Relief Childrens Mucus Relief Expectorant Grape Childrensrelief Expectorant Grape Cough Cough Out Dg Health Mucus Relief Er Diabetic Siltussin Das-na Diabetic Tussin Expectorant Diabetic Tussin Mucus Relief Equaline Mucus Er Equaline Tussin chest congestion Equate Mucus Er Equate Tussin Adult Chest Congestion Expectorant Expectorant 12 Hour Gadavyt Cough Geri-tussin Expectorant Glycerin ether Glycerin guaiacolate Glycero-guaiacol ether Glycerol a-(2-methoxyphenyl) ether Glycerol a-(O-methoxyphenyl)ether Glycerol a-guaiacyl ether Glycerol a-guiacyl ether Glycerol a-monoguaiacol ether Glycerol guaiacolate Glycerol mono(2-methoxyphenyl) ether Glycerol-a-guajakolether Glycerol-alpha-guajakolether Glyceryl guaiacol Glyceryl guaiacol ether Glyceryl guaiacolate Glyceryl guaiacolate ether Glyceryl guaiacyl ether Glyceryl guaicolate Glyceryl guiacolate Glycerylguaiacol Good Neighbor Pharmacy Mucus Er Good Neighbor Pharmacy Mucus Relief Good Neighbor Pharmacy Tabtussin Good Neighbor Pharmacy Tussin Good Sense Mucus Er Good Sense Mucus Relief Good Sense Tussin chest congestion Guaap Guaiacol glycerol ether Guaiacol glyceryl ether Guaiacolglicerinetere Guaiacuran Guaiacurane Guaiacyl glyceryl ether Guaiamar Guaianesin Guaicol glycerine ether Guaicol glyceryl ether Guaifenesin Guaifenesin Extended Release Guaifenesine Guaiphenesin Guaiphenesine Guaiphesin Guiatuss Health Mart Adult Tussin Health Mart Mucus Er Healthmart Chest Congestion Relief Healthy Accents Childrens Mucus Relief Healthy Accents Mucus Relief Healthy Accents Tussin Healthy Accents Tussin Chest Congestion adult Hustosil | Iophen Nr Kids-eeze Chest Relief Leader Adult Tussin Chest Congestion Leader Adult Tussin Mucus Plus Chest Congestion Leader Chest Congestion Relief G450 Leader Cough Tabs Leader Mucus Er Leader Mucus Relief childrens Leader Tabtussin 400 Licorice Coughing Liquid Liqufruta Liquituss Gg Little Remedies Little Colds Mucus Relief Expectorant Melt Aways Methoxypropanediol Methphenoxydiol Metossipropandiolo Mucaplex Mucinex Mucinex For Kids Mucinex Maximum Strength Mucinex for Kids Mucosa Mucus Er Mucus Extended Release Mucus Releif Expectorant Mucus Relief Mucus Relief Chest Mucus Relief Er Mucus Relief Expectorant Mucus Relief Immediate Release O-Methoxyphenyl glyceryl ether Organ-i Nr Organidin NR Pancold S Pneumomist Preferred Plus Chest Congestion Relief Preferred Plus Mucus Er Preferred Plus Tabtussin Premier Value Chest Congestion Relief Propanosedyl Q-tussin Qtussin Quality Choice Mucus Relief Reduton Refenesen Refenesen Chest Congestion Relief Respaire-30 Ritussin Expectorant Robafen Cough Formula Robitussin Robitussin Mucus Plus Chest Congestion Rompe Pecho Rompe Pecho EX Rompe Pecho SF Rugby Mucus Er Rx Act Tussin Chest Congestion Scot-tussin Expectorant Sf Cough Select Brand Coughtab 400 Select Brand Mucus Relief Select Brand Tab Tussin Selecthealth Tussin Dm Shopko Chest Congestion Relief Shoprite Adult Tussin Shoprite Mucus Relief Siltussin Das Siltussin Sa Simpex Guaifenesin Simply Right Mucus Relief Smart Sense Childrens Mucus Relief Smart Sense Mucus Er Smart Sense Tussin adult Sunmark Mucus Er Sunmark Tussin Sunmark Tussin chest congestion The Medicine Shoppe Chest Congestion Relief Topcare Mucus Er Topcare Mucus Relief Topcare Tussin Chest Congestion Topcare Tussin mucus plus chest congestion Tussin Tussin Adult chest congestion Tussin Chest Tussin Chest Congestion Adult Non Drowsy Tussin Chest Congestion Non Drowsy Tussin EXPECTORANT Tussin Non Drowsy Tussin Original Tussin adult chest congestion Tussin adults non drowsy Tussin expectorant for adults Tussin mucus plus chest congestion Ultra Tuss Wal Tussin adult chest congestion a-Glyceryl guaiacol ether a-Glyceryl guaiacolate ether alpha-Glyceryl guaiacol ether alpha-Glyceryl guaiacolate ether guaiphenesin p-Cresyl acetate |
| | 22 | | Dextromethorphan | approved | Phase 3 | 122 | 125-71-3 | 5360696, 5362449 | ( )-3-Methoxy-N-methylmorphinon ( )-cis-1,3,4,9,10,10a-Hexahydro-6-methoxy-11-methyl-2H-10,4alpha-iminoethanophenanthren (+)-3-Methoxy-17-methylmorphinan (-)-3-Methoxy-N-methylmorphinan (9alpha,13alpha,14alpha)-17-methyl-3-(methyloxy)morphinan 125-69-9 (hydrobromide) 125-70-2 125-71-3 18046-32-7 18609-21-7 (hydrochloride) 3-Methoxy-17-methyl-9alpha,13alpha,14alpha-morphinan 3-Methoxy-17-methylmorphinan 32062-10-5 4-21-00-01367 (Beilstein Handbook Reference) 6700-34-1 (hydrobromide, mono-hydrate) 9alpha,13alpha,14alpha-Morphinan, 3-methoxy-17-methyl- (8CI) AC-13098 AC1L1EYT Albutussin Antussan BA 2666 BPBio1_000503 BRD-K33211335-337-03-7 BRN 0088549 BSPBio_000457 Balminil DM Balminil DM Children Bayer Select Flu Relief Bayer Select Head & Chest Cold Bayer Select Night Time Cold Benylin Adult Formula Cough Suppressant Benylin DM Benylin DM (TN) Benylin DM 12 Hour Benylin DM for Children Benylin DM for Children 12 Hour Benylin Pediatric Cough Suppressant C06947 CHEBI:128891 CHEBI:4470 CHEBI:580686 CHEMBL22207 CHEMBL52440 CID3008 CID5360696 CID5362449 Calmylin #1 Canfodion Cerose-DM Chloraseptic DM Contac Day & Night Cold/Flu Day Caplets Contac Jr. Non-drowsy Formula Contac Nighttime Cold Medicine Contac Severe Cold Formula Maximum Strength Contac Severe Cold Formula Non-Drowsy Coricidin Syrup Cosylan Cough Medicine soothing relief Cough-X Creo-Terpin D-Methorphan D-Methorphan Hydrobromide D03742 DB00514 DEA No. 9210 DM DMHM DXM Delsym Delsym (dextromethorphan) Delsym Cough Formula Delta-Methorphan Demorphan Demorphan Hydrobromide Demorphan hydrobromide Demorphine Destrometerfano Destrometerfano [DCIT] Destrometerfano [Dcit] Dextromethorfan Dextromethorfan [Czech] Dextromethorphan Dextromethorphan (USP) Dextromethorphan Bromhydrate Dextromethorphan Bromide Dextromethorphan Hydrobromide Dextromethorphan [USP:INN:BAN] Dextromethorphan hydrobromide Dextromethorphan hydrobromide OROS Tablets Dextromethorphan hydrobromide [BAN:JAN] Dextromethorphan hydrobromide monohydrate Dextromethorphane Dextromethorphane [INN-French] Dextromethorphanum Dextromethorphanum [INN-Latin] Dextrometorfano Dextrometorfano [INN-Spanish] Dextrometorphan Dextromorphan Dextrométhorphane Dexyromethorphan | Diabe-Tuss DM Syrup Dimacol Dimetapp DM Dormetan Dormethan Drixoral Cough Drixoral Cough & Congestion Drixoral Cough & Sore Throat EINECS 204-751-7 EINECS 204-752-2 Endotussin-NN Endotussin-NN Pediatric HMS2090C08 HSDB 3056 Hihustan M. Hold Hold DM Koffex DM L-Methorphan LS-91837 LS-91838 Levomethorphan Levomethorphan [BAN:DCF:INN] Levomethorphan [Ban:Dcf:Inn] Levomethorphan [INN:BAN:DCF] Levomethorphane Levomethorphane [INN-French] Levomethorphanum Levomethorphanum [INN-Latin] Levometorfano Levometorfano [INN-Spanish] Lopac-D-2531 Lopac0_000337 MLS000758303 Medicon Methorate Methorate Hydrobromide Methorphan Metrorat Mielim Y Mas MolPort-003-940-943 MolPort-004-285-957 Morphinan, 3-methoxy-17-methyl-, (9-alpha,13-alpha,14-alpha)- (9CI) NCGC00015333-01 NCGC00015333-02 NCGC00015333-04 NCGC00162126-01 Naldecon-DX Novahistex DM Novahistine DM Ornex Severe Cold Formula Orthoxicol PediaCare 1 PediaCare Cough-Cold Formula Pertussin CS Children's Strength Pertussin DM Extra Strength Prestwick0_000359 Prestwick1_000359 Prestwick2_000359 Prestwick3_000359 Prestwick_686 RACEMETHORPHAN Robitussin CF Robitussin Cold & Cough Robitussin Cough Calmers Robitussin DM Robitussin Maximum Strength Cough Robitussin Maximum Strength Cough Suppressant Robitussin Pediatric Robitussin Pediatric Cough Robitussin Pediatric Cough & Cold Robitussin Pediatric Cough Suppressant Robitussin Pediatric Night Relief Romilar Rondec dm Ru-Tuss Expectorant SPBio_002378 St. Joseph Cough Syrup Sucrets 4 Hour Cough Suppressant Sudafed Cough Syrup Triaminic Triaminic DM Long Lasting for Children Trind-DM Trocal Tusilan Tussade Tussar DM Tussi-Organidin Tussi-Organidin DM NR Tussi-Organidin DM-S NR Tylenol Cold No Drowsiness Tylenol Cold and Flu Multi-Symptom Tylenol Cold and Flu No Drowsiness Tylenol Cough + Decongestant Liquid Tylenol Cough Liquid Tylenol Flu No Drowsiness Gelcaps UNII-7355X3ROTS Vicks 44 Cough Relief Viro-Med d-Methorphan delta-Methorphan dextromethorphan l-Methorphan |
| | 23 | | Vancomycin | approved | Phase 3 | 305 | 1404-90-6 | 441141, 14969 | (1S,2R,18R,22S,25R,28R,40S)-22-(2-amino-2-Oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid (2.2Sp,3.5sa,2.6sp)-O(4.2),C(3.4):c(5.4),O(4.6):c(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-beta-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-beta-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine] 1404-90-6 1404-93-9 (hydrochloride) 64685-75-2 (sulfate) AC1L24VU AC1L9AMI AC1Q29OH BIDD:GT0353 C06689 C66H75Cl2N9O24 CHEBI:28001 CHEMBL262777 CID14969 CID441141 CID5311496 CID6426898 CID6917992 D00212 DB00512 EINECS 215-772-6 HSDB 3262 LMPK14000004 LS-161387 | Lopac0_001267 MolPort-001-794-649 NCGC00162383-02 Prestwick0_000497 Prestwick1_000497 Prestwick2_000497 SPBio_002314 UNII-6Q205EH1VU VAN VANCOMYCIN Vancocin Vancocin (TN) Vancocin HCL Vancomicina Vancomicina [INN-Spanish] Vancomycin Vancomycin (USP) Vancomycin HCL Vancomycin Hydrochloride Vancomycin [USAN:INN:BAN] Vancomycine Vancomycine [INN-French] Vancomycinum Vancomycinum [INN-Latin] nchembio.350-comp1 | |
| | 24 | | Dalteparin | approved | Phase 3 | 281 | 9041-08-1 | | Daltepariininatrium Dalteparin Sodyum Dalteparin sodium Dalteparin sodná sůl Dalteparin-nátrium Dalteparina sódica | Dalteparinnatrium Dalteparino natrio druska Dalteparinum Natricum Dalteparyna sodowa Daltéparine sodique Fragmin Heparin Fragment KABI 2165 Tedelparin |
| | 25 | | Aldesleukin | approved | Phase 3, Phase 2, Phase 1 | 387 | 85898-30-2 | | IL-2 Interleukin-2 precursor | Proleukin T-cell growth factor TCGF | |
| | 26 | | Tazobactam | approved | Phase 3 | 87 | 89786-04-9 | 123630 | (2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4 (2S,3S,5R)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide 89785-84-2 89786-04-9 AC-7620 AC1L3X07 BIDD:GT0212 C07771 CHEBI:100207 CHEMBL404 | CID123630 CL-298741 CL298741 D00660 DB01606 MolPort-002-500-123 TAZ Tazobactam Tazobactam (JAN/USAN/INN) YTR-830H YTR830H | |
| | 27 | | Heparin | approved, investigational | Phase 3 | 719 | 9005-49-6 | 772, 46507594 | 101921-26-0 102-94-3 102785-31-9 104521-37-1 11078-24-3 11129-39-8 12656-11-0 2-o-sulfohexopyranuronosyl-(1->4)-2-deoxy-3-o-sulfo-2-(sulfoamino)hexopyranosyl-(1->4)-2-o-sulfohexopyranuronosyl-(1->4)-2-acetamido-2-deoxy-6-o-sulfohexopyranose 37324-73-5 6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid 9041-08-1 9045-22-1 9075-96-1 913079-23-9 91449-79-5 AC1L19ZN AC1L1ROY ALFA 87-120 ALFA 87-163 ALFA 87-198 ALFA 87-81 ALFA 88-247 AR-1E4539 Allocinnamic acid Ardeparin Ardeparin sodium Arteven Bemiparin Bemiparin sodium CID772 CID8784 CY 216 Calciparine Certoparin Clexane Clivarin Clivarine Cy 222 D006495 D017984 DB00407 DB01225 Dalteparin Dalteparin sodium Depo-Heparin EINECS 232-681-7 EMT 966 EMT 967 EMT-966 EMT-967 EMT966 EMT967 Enoxaparin Enoxaparin sodium Enoxaparine Eparina Eparina [DCIT] FR 860 Fluxum Fragmin A Fragmin B Fragmin IV Fraxiparin H 2149 HSDB 3094 Hed-heparin Hep Flush Kit in plastic container Hep-Lock Hep-Lock U/P Hep-lock Heparin Heparin CY 216 Heparin Lock Flush Heparin Lock Flush in plastic container Heparin Lock Flush preservative free Heparin Lock Flush preservative free in plastic container Heparin Sodium Heparin natrium Heparin sodium Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container Heparin sodium 1,000 units in dextrose 5% in plastic container Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container Heparin sodium 10,000 units in dextrose 5% Heparin sodium 10,000 units in dextrose 5% in plastic container Heparin sodium 10,000 units in sodium chloride 0.45% Heparin sodium 10,000 units in sodium chloride 0.9% Heparin sodium 12,500 units in dextrose 5% Heparin sodium 12,500 units in dextrose 5% in plastic container Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container Heparin sodium 12,500 units in sodium chloride 0.9% Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container Heparin sodium 2,000 units in dextrose 5% in plastic container Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container Heparin sodium 20,000 units and dextrose 5% in plastic container Heparin sodium 20,000 units in dextrose 5% in plastic container Heparin sodium 25,000 units and dextrose 5% in plastic container | Heparin sodium 25,000 units in dextrose 5% Heparin sodium 25,000 units in dextrose 5% in plastic container Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container Heparin sodium 25,000 units in sodium chloride 0.9% Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container Heparin sodium 5,000 units in dextrose 5% in plastic container Heparin sodium 5,000 units in sodium chloride 0.45% Heparin sodium 5,000 units in sodium chloride 0.9% Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container Heparin sodium in plastic container Heparin sodium preservative Free Heparin sulfate Heparin sulphate Heparin, Low Molecular Weight Heparin, Low-Molecular-Weight Heparin, sodium salt Heparina Heparina [INN-Spanish] Heparinate Heparine Heparine [INN-French] Heparinic acid Heparinsodiumsalt Heparinum Heparinum [INN-Latin] Heparinum natricum Hepathrom Hepflush-10 Inno-Hep Innohep Isocinnamic acid KB 101 Kabi 2165 LHN 1 LMWH Lioton 1000 Lipo-hepin Liquaemin Liquaemin Lock Flush Liquaemin Sodium Liquaemin sodium preservative free Liquemin Logiparin Lovenox Lovenox HP Low Molecular Weight Heparin Low molecular weight heparin Low molecular weight heparin sodium Low-Molecular-Weight Heparin Minolteparin sodium MolPort-003-760-257 Multiparin NSC174025 Nadroparin Nadroparine Novoheparin OP 386 OP 622 Octaparin PK 10,169 PK-10,169 PK-10169 PK10,169 PK10169 Pabyrin Panheprin Parnaparin Parnaparin sodium Parvoparin Pularin Reviparin Reviparin sodium Ro 11 Sandoparin Sodium acid heparin Sodium heparin Sodium heparinate Subeparin Sublingula Thromboliquine Tinzaparin Tinzaparin sodium Triofiban UNII-12M44VTJ7B UNII-3S182ET3UA UNII-E47C0NF7LV UNII-T2410KM04A UNII-ZZ45AB24CA Vetren Vitrum AB WY 90493RD alpha-Heparin cis-.beta.-Carboxystyrene cis-Cinnamic acid enoxaparin heparin | |
| | 28 | | Darbepoetin alfa | approved, investigational | Phase 3, Phase 2 | 160 | 11096-26-7 | | | Epoetin Erythropoietin precursor | |
| | 29 | | Caspofungin | approved | Phase 3, Phase 2 | 61 | 179463-17-3, 162808-62-0 | 468682, 2826718 | (4R,5S)-5-((2-Aminoethyl)amino)-N(2)-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(P-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (6-1)-peptide (4R,5S)-5-((2-Aminoethyl)amino)-N(sup 2)-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (6-1)-peptide (4R,5S)-5-((2-aminoethyl)amino)-N(2)-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (6-1)-peptide 1-[(4R,5S)-5-[(2-Aminoethyl)amino]-N(2)-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]-pneumocandin b0 1-[(4R,5S)-5-[(2-aminoethyl)amino]-N(2)-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]-pneumocandin B0 162808-62-0 AC1L45LR AC1LAHR5 AC1MCVUN AR-1K4318 CASPO CHEBI:474180 CHEMBL374999 CHEMBL499808 CID151068 CID2826718 CID468682 Cancidas Cancidas (TM) | Cancidas (TN) Capsofungin Caspofungin Caspofungin (INN) Caspofungin [INN] Caspofungin acetate D07626 DB00520 HSDB 7476 L-743,872 LS-186994 LS-187303 LS-187635 M991 MK-0991 N-{(2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-12-[(2-aminoethyl)amino]-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11,15-trihydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide Pneumocandin B0, 1-[(4R,5S)-5-[(2-aminoethyl)amino]-N2-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]- (9CI) UNII-F0XDI6ZL63 [1(R)-hydroxyethyl]-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0(9,13)]heptacosane-2,5,8,14,17,23-hexaone diacetate n-{(2r,6s,9s,11r,12s,14as,15s,20s,23s,25as)-12-[(2-aminoethyl)amino]-20-[(1r)-3-amino-1-hydroxypropyl]-23-[(1s,2s)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11,15-trihydroxy-6-[(1r)-1-hydroxyethyl]-5,8,14,19,22,25-hexaoxotetracosahydro-1h-dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-10,12-dimethyltetradecanamide nchembio.184-comp7 |
| | 30 | | Amphotericin B | approved, investigational | Phase 3 | 117 | 1397-89-3 | 14956, 5280965 | 12633-72-6 1397-89-3 30782-62-8 5-18-10-00525 (Beilstein Handbook Reference) 54482-28-9 8055-20-7 AB00513832 ABLC AC1L1CN2 AC1L24V6 AC1L70KF AC1L73U6 AC1NQXTD AC1NTQ32 AC1NUQG4 AC1NY9JC AC1O7GCZ AC1O8FQV AC1O8PFK AI3-26528 AMPH-B AMPH-b Abelcet Abelecet AmBisome (TN) Ambap1397-89-3 Ambisome Amfotericina B Amfotericina B [INN-Spanish] Ampho-Moronal Amphocin Amphomoronal Amphortericin B Amphotec Amphotec (TN) Amphotericin Amphotericin .BETA. Amphotericin B Amphotericin B (JP15/USP/INN) Amphotericin B Cholesterol Dispersion Amphotericin B Cholesteryl Sulfate Complex Amphotericin B Colloidal Dispersion Amphotericin B [USAN:INN:JAN] Amphotericin B, Lipid-based Amphotericin B, Streptomyces sp. Amphotericin-B Amphotericine B Amphotericine B [INN-French] Amphotericinum Amphotericinum B Amphotericinum B [INN-Latin] Amphotherizin Amphotherizin [German] Amphotéricine B Amphozone BIDD:GT0351 BPBio1_000374 BRN 0078342 BSPBio_000340 C-AmB C06573 C47H73NO17 CCRIS 5963 CHEBI:2682 CHEMBL1200646 CHEMBL267345 CID10533925 CID10629638 CID10677275 CID14956 | CID1972 CID352546 CID354192 CID5280965 CID5386092 CID5458486 CID5771695 CID6604295 CID6708817 CID6713692 CID9919339 D00203 DB00681 DivK1c_007045 EINECS 215-742-2 Fungilin Fungisome Fungisone Fungizone Fungizone (TN) HMS1569A22 HSDB 3008 HSDB 3008 IAB Halizon I06-0257 KBio1_001989 KBio2_000551 KBio2_003119 KBio2_005687 KBioGR_002298 KBioSS_000551 LMPK06000002 LNS-AmB LS-187721 LS-93 Liposomal Amphotericin B Liposomal amphotericin b MLS002702966 MolPort-006-392-260 Mysteclin-F NCGC00014913 NCGC00090808-01 NCGC00098014-01 NCGC00179595-01 NCI527017 NCI60_004288 NCIStruc1_001042 NCIStruc2_000920 NKTR-024 NS 718 NSC 527017 NSC-527017 NSC527017 Prestwick0_000410 Prestwick1_000410 Prestwick2_000410 Prestwick3_000410 Prestwick_721 SMP1_000302 SMR001566780 SPBio_000715 SPBio_002279 ST50999656 SinuNase SpecPlus_000949 Spectrum2_000818 Spectrum4_001779 Spectrum_000111 UNII-7XU7A7DROE amophotericin B amphotericin B liposomal amphotericin b |
| | 31 | | Iron | approved | Phase 3, Phase 1, Phase 2 | 1021 | 7439-89-6 | 23925 | 02583_FLUKA 12310_ALDRICH 12310_RIEDEL 129048-51-7 14067-02-8 161135-39-3 190454-13-8 195161-83-2 199281-22-6 209309_ALDRICH 209309_SIAL 255637_ALDRICH 266213_ALDRICH 266256_ALDRICH 267945_ALDRICH 267953_ALDRICH 26Fe 338141_ALDRICH 356808_ALDRICH 356824_ALDRICH 356832_ALDRICH 39344-71-3 3ZhP 413054_ALDRICH 443783-52-6 44890_ALDRICH 44890_FLUKA 675141-17-0 70884-35-4 73135-38-3 7439-89-6 8011-79-8 8053-60-9 AC1L2N38 ATW 230 ATW 432 Ancor B Ancor en 80/150 Armco iron Atomel 28 Atomel 300M200 Atomel 500M Atomel 95 Atomiron 44MR Atomiron 5M Atomiron AFP 25 Atomiron AFP 5 C00023 C3518_SIAL C3518_SIGMA CCRIS 1580 CHEBI:18248 CID23925 Carbonyl iron Copy Powder CS 105-175 D007501 DB01592 DSP 1000 DSP 128B DSP 135 DSP 135C DSP 138 Dexiron Diseases (animal), iron overload Diseases, iron overload EF 1000 EF 250 EFV 200/300 EFV 250 EFV 250/400 EINECS 231-096-4 Ed-In-Sol | Eisen F 60 (metal) FE FT 3 (element) Fe Fe-40 Fe1+ Feraheme Feronate Ferretts Ferrlecit Ferro-Caps Ferro-Time Ferrousal Ferrovac E Ferrum GS 6 HF 2 (element) HL (iron) HQ (metal) HS (iron) HS 4849 HSDB 604 Hemocyte Hierro Hoeganaes ATW 230 Hoeganaes EH IRMM524A_FLUKA IRMM524B_FLUKA IRON Infufer Iron Iron (Fe) Iron (Fe1+) Iron ion (Fe+) Iron ion(1+) Iron monocation Iron standard for AAS Iron(1+) Iron(1+) ion Iron(III) nitrate solution Iron, elemental Iron, ion (Fe1+) Iron, ion (Fe1+) (8CI,9CI) LOHA LS-3196 MolPort-003-925-001 NC 100 PZh-1M3 PZh-2 PZh1M1 PZh2M PZh2M1 PZh2M2 PZh3 PZh3M PZh4M PZhO Remko SUY-B 2 Siderol UNII-E1UOL152H7 Venofer Vitedyn-Slo Yieronia fer ferrous ascorbate ferrous fumarate ferrous gluconate ferrous glycine sulfate ferrous iron ferrous succinate ferrous sulfate hierro |
| | 32 | | Fentanyl | approved, illicit, investigational | Phase 3 | 705 | 437-38-7 | 3345 | 1-Phenethyl-4-(N-phenylpropionamido)piperidine 1-Phenethyl-4-N-propionylanilinopiperidine 437-38-7 5-22-08-00049 (Beilstein Handbook Reference) 80832-90-2 990-73-8 (citrate) AC1L1FQ2 Abstral Actiq BIDD:GT0555 BRN 0494484 CHEBI:119915 CHEMBL596 CID3345 D00320 DB00813 Duragesic Duragesic (TN) Duragesic-100 Duragesic-12 Duragesic-25 Duragesic-50 Duragesic-75 Durogesic EINECS 207-113-6 Fentanest Fentanil Fentanil [DCIT] Fentanila Fentanila [INN-Spanish] Fentanilo Fentanyl Fentanyl (JAN/USAN/INN) Fentanyl - Novaplus Fentanyl Citrate Fentanyl [INN:BAN] Fentanyl citrate Fentanyl-100 | Fentanyl-12 Fentanyl-25 Fentanyl-50 Fentanyl-75 Fentanylum Fentanylum [INN-Latin] HSDB 3329 IONSYS JNS020QD L001275 LS-124439 Lazanda Matrifen MolPort-003-847-369 N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide N-(1-Phenethyl-4-piperidyl)propionanilide N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide N-Phenethyl-4-(N-propionylanilino)piperidine N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide NCGC00168252-01 Nasalfent Oprea1_152073 Oprea1_207148 PDSP1_000860 PDSP2_000846 Pentanyl Phentanyl Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI) R 4263 Rapinyl Sentonil Sublimase Sublimaze Subsys UNII-UF599785JZ fentanyl | |
| | 33 | | Mycophenolate mofetil | approved, investigational | Phase 3, Phase 2, Phase 1 | 898 | 128794-94-5 | 5281078 | 115007-34-6 128794-94-5 140401-05-4 2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate 2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E) AC-1562 AC1NQXZW AC1Q6O6X AR-1J6939 BB_NC-2566 C07908 C23H31NO7 CHEMBL1456 CID5281078 CellCept CellCept, RS 61443, TM-MMF, Mycophenolate mofetil Cellcept Cellcept (TN) D00752 DB00688 HMS2090A03 | HSDB 7436 I01-0898 I06-1947 LS-172272 LS-75572 ME-MPA MMF MMF CellCept(TM) MolPort-000-883-800 Munoloc Mycophenolate Mofetil Mycophenolate mofetil (JAN/USAN) Mycophenolic acid morpholinoethyl ester Mycophenylate mofetil NCGC00159459-02 NCGC00159459-03 NSC724229 R-99 RS 61443 RS-61443 RS-61443-190 S1501_Selleck TL8000648 TM-MMF UNII-9242ECW6R0 ZINC21297660 mycophenolate mofetil |
| | 34 | | Carboplatin | approved | Phase 2, Phase 3, Phase 1, Phase 0 | 1885 | 41575-94-4 | 10339178, 498142, 38904 | (SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum /h1-3H2,(H,7,8)(H,9,10) /q 1,1-Cyclobutanedicarboxylate diammine platinum (II) 1,1-Cyclobutanedicarboxylate diammine platinum(II) 2*-1 2*1H2 41575-94-4 70903-55-8 AC-1457 AC1L8I6U Ambap41575-94-4 BSPBio_003145 C 2538 C2043 C2538_SIGMA C6H10N2O4Pt CBDCA CCRIS 3404 CHEBI:31355 CHEMBL1351 CHEMBL288376 CID10339178 CID2567 CID38904 CID426756 CID498142 CID5352133 CID6398587 CID6603770 Carbopaltin Carboplatin Carboplatin (JAN/USP/INN) Carboplatin (USAN) Carboplatin [USAN:INN:BAN:JAN] Carboplatine Carboplatine [French] Carboplatino Carboplatino [Spanish] Carboplatinum Carboplatinum [Latin] Cbdca Cyclobutane-1,1-dicarboxylate D01363 DB00958 Diammine(1,1-cyclobutanedicarboxylato)platinum (II) Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum Diammine-1,1-cyclobutane dicarboxylate platinum II DivK1c_000892 EINECS 255-446-0 EU-0100230 Ercar HMS1921J16 HMS2090M05 HMS2092B22 HMS502M14 HSDB 6957 I14-2390 IDI1_000892 IUPAC: Azane InChI=1/C6H8O4.2H2N.Pt/c7-4(8)6(5(9)10)2-1-3-6 | JM 8 JM-8 KBio1_000892 KBio2_002009 KBio2_004577 KBio2_007145 KBio3_002645 KBioGR_000713 KBioSS_002009 LS-117689 Lopac-C-2538 Lopac0_000230 MolPort-003-665-501 MolPort-003-845-609 NCGC00015223-01 NCGC00093695-01 NCGC00094961-01 NCGC00094961-02 NCGC00094961-03 NCGC00162099-01 NCGC00162099-02 NCGC00167800-01 NCGC00178242-01 NINDS_000892 NSC 201345 NSC 241240 NSC-241240 NSC201345 NSC241240 Paraplatin Paraplatin (TN) Paraplatin, Carboplatin Paraplatin-AQ Platinum(+2) Cation Platinum(II), (1, 1-cyclobutanedicar Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2) Platinum, {diammine[1,1-cyclobut S1215_Selleck SPBio_000716 SPECTRUM1502106 Spectrum2_000898 Spectrum3_001503 Spectrum4_000337 Spectrum5_001094 Spectrum_001529 UNII-BG3F62OND5 azanide carboplatin cis -Diammine[1,1-cyclobutane-dicarboxylato] platinum cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II) cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(ii) cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II) cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II) cis-Diammine(1,1-cyclobutanedicarboxylato) platinum cis-Diammine(1,1-cyclobutanedicarboxylato)platinum cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II) cis-Diammine(cyclobutanedicarboxylato)platinum II cyclobutane-1,1-dicarboxylic acid diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum nchembio.573-comp10 nchembio773-comp2 nchembio873-comp3 platinum(2+) |
| | 35 | | Cefepime | approved | Phase 3, Phase 1 | 33 | 88040-23-7 | 5479537 | (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(1-methylpyrrolidinium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 1-(((6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methylpyrrolidinium hydroxide, inner salt, 7(sup 2)-(Z)-(O-methyloxime) 7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-[(1-methylpyrrolidinium-1-yl)methyl]-3,4-didehydrocepham-4-carboxylate 88040-23-7 AC1NUIFH Axepim BMY 28142 BMY-28142 C08111 C19H24N6O5S2 CFPM CHEBI:478164 CHEMBL186 CID5479537 Cefepima Cefepima [Spanish] Cefepima [spanish] | Cefepime Cefepime (USAN/INN) Cefepime Hydrochloride Cefepime [USAN:INN] Cefepime dihydrochloride monohydrate Cefepime hydrochloride Cefepimum Cefepimum [Latin] Cefepimum [latin] Cepimax Cepimex D02376 DB01413 HMS2089M18 LS-178033 Maxcef Maxipime UNII-807PW4VQE3 ZINC03871924 cefepime |
| | 36 | | Vidarabine | approved | Phase 3, Phase 2, Phase 1 | 238 | 24356-66-9 | 32326, 21704 | (+)-Cyclaradine .beta.-Adenosine .beta.-D-Adenosine 1odi 2-(6-AMINO-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol 2946-52-3 2fqy 2gl0 30143-02-3 3080-29-3 3228-71-5 4005-33-8 46946-45-6 46969-16-8 524-69-6 5536-17-4 58-61-7 9-Arabinosyladenine 9-beta-D-Arabinofuranosyl-9H-purin-6-amine 9-beta-D-Arabinofuranosyl-adenine 9-beta-D-Arabinofuranosyladenine 9-beta-D-arabinofuranosyl-adenine 9-β-D-arabinofuranosyl-9H-purin-6-amine 9-β-D-arabinofuranosyladenine A 9251 A0152 A4036_SIGMA A4676_SIGMA A5762_SIGMA A9251_SIGMA AC1L18OL AC1L1U8O AC1L2IWM AC1L2SCM AC1O4WIN AC1O8PY7 AC1Q1ID3 AC1Q4Y1Z AC1Q52XU ADENOSINE, U.S.P. ADN AI3-52413 AI3-52821 AR-1H6029 ARA-A NSC 247519 Ade-Rib Adenine Arabinoside Adenine arabinoside Adenine nucleoside Adenine riboside Adenine xyloside Adenocard Adenocard (TN) Adenocard, Adenosine Adenocor Adenoscan Adenoscan (TN) Adenosin Adenosin [German] Adenosine (JAN/USP) Adenosine [USAN:BAN] Adenosine arabinose Adenosine-8-14C Adensoine Ambap5536-17-4 Ara A Ara-A Ara-ATP Araadenosine Arabinoside Adenine Arabinoside adenine Arabinosyl Adenine Arabinosyl adenine Arabinosyl-adenine Arabinosyladenine Arasena-A Armes Armes (TN) BB_NC-0565 BPBio1_000898 BRN 0624881 BSPBio_000816 BSPBio_001796 BSPBio_002000 Bio1_000437 Bio1_000926 Bio1_001415 Boniton C00212 CAS-5536-17-4 CCRIS 2557 CCRIS 3383 CHEBI:136932 CHEBI:16335 CHEBI:45327 CHEMBL1090 CHEMBL20247 CHEMBL477 CI 673 CI-673 CID102198 CID191 CID21704 CID60961 CID6420052 CID6713976 CPD000471872 Caswell No. 010B D000241 D00045 D06298 DB00640 DivK1c_000191 EINECS 200-389-9 EINECS 217-911-6 EINECS 226-893-9 EU-0100123 FT-0082881 HMS1570I18 HMS1920A13 HMS1921K05 HMS2090F06 HMS2091G13 HMS2092C16 HMS500J13 HSDB 6514 | I01-1121 IDI1_000191 KBio1_000191 KBio2_002418 KBio2_004986 KBio2_007554 KBio3_001296 KBio3_001500 KBioGR_001224 KBioSS_002424 L000094 LS-15059 LS-15085 Lopac0_000123 MEDR-640 MLS000069638 MLS000699527 MLS001066352 MLS001333133 MLS001333134 MLS002153227 MLS002153992 MolPort-001-785-903 MolPort-001-838-229 MolPort-003-666-308 Myocol NCGC00016656-01 NCGC00023673-03 NCGC00023673-04 NCGC00023673-05 NCGC00023673-06 NCGC00023673-07 NCGC00094579-01 NCGC00094579-02 NCGC00094579-03 NCGC00094579-04 NCGC00178869-01 NCGC00179417-01 NCI60_003823 NCI60_037192 NCIOpen2_003303 NCIOpen2_005376 NINDS_000191 NSC 247519 NSC 404241 NSC 627048 NSC 7359 NSC 7652 NSC-404241 NSC247519 NSC404241 NSC627048 NSC70422 NSC7359 NSC7652 NSC80832 NSC87676 NSC91041 Nucleocardyl PDSP1_001036 PDSP2_001020 Pallacor Polyadenosine Polyriboadenosine Prestwick0_000768 Prestwick1_000768 Prestwick2_000768 Prestwick3_000768 Prestwick_983 RAB S1647_Selleck S1784_Selleck SAM002564191 SMP1_000312 SMR000058216 SMR000225041 SMR000471872 SMR001233326 SPBio_001194 SPBio_001491 SPBio_002755 SPECTRUM1500107 SPECTRUM1500609 SR 96225 SR-96225 STK361815 SUN-Y4001 Sandesin Spectrum2_001257 Spectrum2_001336 Spectrum3_000288 Spectrum3_000580 Spectrum4_000782 Spectrum5_001429 Spectrum_001894 Spongoadenosine TL8003749 UNII-3XQD2MEW34 UNII-K72T3FS567 USAF CB-10 V0098 VIRDARABINE Vidarabin Vidarabina Vidarabina [DCIT] Vidarabine Vidarabine (JAN) Vidarabine anhydrous Vidarabinum Vira ATM Vira-A Vira-A, Vidarabine XA Xylosyl A Xylosyladenine ZINC00970363 ZINC02169830 adenine-D-ribose adenosine alpha-Ara A beta-Adenosine beta-Ara A beta-D-Adenosine bmse000061 nchembio.143-comp9 nchembio.186-comp109 nchembio.64-comp4 nchembio706-5 |
| | 37 | | Bleomycin | approved | Phase 3, Phase 2 | 144 | 11056-06-7 | 5360373 | (betaR)-N(alpha)-{[6-amino-2-((1S)-3-amino-1-{[(2S)-2,3-diamino-3-oxopropyl]amino}-3-oxopropyl)-5-methylpyrimidin-4-yl]carbonyl}-beta-{2-O-[3-O-(aminocarbonyl)-alpha-D-mannopyranosyl]-alpha-L-gulopyranosyloxy}-N-[(1R,2S,3S)-5-({(1S,2R)-1-[({2-[4-({[3-(dimethylsulfonio)propyl]amino}carbonyl)-2,4'-bi-1,3-thiazol-2'-yl]ethyl}amino)carbonyl]-2-hydroxypropyl}amino)-3-hydroxy-4-methyl-5-oxopentan-2-yl]-L-histidinamide 11056-06-7 11116-31-7 1400-95-9 3-[[2-[2-[2-[[(2S,3R)-2-[[(2S,3S,4R)-4-[[(2S)-2-[[6-amino-2-[(1S)-3-amino-1-[[(2S)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2R,3S,4S,5S,6S)-3-[(2R,3S,4S,5R,6R)-4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium 3-[[2-[2-[2-[[(2S,3R)-2-[[(2S,3S,4R)-4-[[(2S,3R)-2-[[6-amino-2-[(1S)-3-amino-1-[[(2S)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2R,3S,4S,5S,6S)-3-[(2R,3S,4S,5R,6R)-4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium 3-[[2-[2-[2-[[(2S,3R)-2-[[(2S,3S,4R)-4-[[(2S,3R)-2-[[6-amino-2-[(1S)-3-amino-1-[[(2S)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[3-[4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium 37208-04-1 37293-16-6 37353-43-8 9041-93-4 9041-93-4 (sulfate (salt)) AC1L9UFF AC1NSEJD AC1NUTOQ BLM Blenoxane Bleo Bleocin Bleogin Bleomicin Bleomicina Bleomicina [INN-Spanish] Bleomycin Bleomycin A(2) Bleomycin A2 Bleomycin A2 & Bleomycin B2. Bleomycin B(2) Bleomycin B2 Bleomycin sulfate Bleomycin sulphate | Bleomycine Bleomycine [INN-French] Bleomycins Bleomycinum Bleomycinum [INN-Latin] C06854 C55H85N17O21S3 C55H86N17O21S3 CCRIS 2754 CHEBI:3139 CHEMBL403664 CID456190 CID5360373 CID5460769 DB00290 EINECS 234-356-5 HSDB 3208 LMPK14000006 LS-44860 LS-524 N(1)-[3-(dimethylsulfonio)propyl]bleomycinamide N1-(3-(Dimethylsulfonio)propyl)bleomycinamide NDC 0015-3010 NSC 125066 Pingyangmyvin A2 STOCK1N-74760 UNII-13M89UEA7W UNII-40S1VHN69B Zhengguangmycin A2 Zhengguangmycin A2 [Chinese] bleomycin bleomycin a2 | |
| | 38 | | Methylprednisolone | approved | Phase 3, Phase 2, Phase 1 | 1082 | 83-43-2 | 6741 | (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one (6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione .DELTA.1-6.alpha.-Methylhydrocortisone 1-Dehydro-6alpha-methylhydrocortisone 1-dehydro-6alpha-Methylhydrocortisone 1-dehydro-6α-methylhydrocortisone 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione 11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 121673-01-6 4-08-00-03498 (Beilstein Handbook Reference) 46436_FLUKA 46436_RIEDEL 570-35-4 6 Methylprednisolone 6-Methylprednisolone 6-alpha-Methylprednisolone 6.alpha.-Methylprednisolone 6923-42-8 6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 6alpha-Methylprednisolone 6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 83-43-2 A-methapred AC1L1N7A Artisone-Wyeth Artisone-wyeth BPBio1_000174 BRD-K35240538-001-03-1 BRN 2340300 BSPBio_000158 Besonia Bio-0658 CHEBI:6888 CHEMBL650 CID6741 CPD000058330 D00407 D008775 DB00959 Depo-Medrol (acetate) Depo-medrol Dopomedrol EINECS 201-476-4 Esametone Firmacort HMS1568H20 HMS2090B13 HSDB 3127 LMST02030178 LS-118498 Lemod M0639_SIGMA M1665 MEPRDL MLS000028541 MLS001148159 MLS002207191 Medesone Medixon Medlone 21 | Medrate Medrol Medrol (TN) Medrol Adt Pak Medrol Dosepak Medrol adt pak Medrol dosepak Medrol, Solu-Medrol, Medrone, Methylprednisolone Medrone Mesopren Metastab Methyleneprednisolone Methylprednisolon Methylprednisolone Methylprednisolone (JP15/USP/INN) Methylprednisolone [USAN:INN:BAN:JAN] Methylprednisolone, 6-alpha Methylprednisolonum Methylprednisolonum [INN-Latin] Metilbetasone Metilprednisolona Metilprednisolona [INN-Spanish] Metilprednisolone Metilprednisolone [DCIT] Metilprednisolone [Dcit] Metipred Metrisone Metrocort Metysolon Moderin MolPort-002-528-554 NCGC00022735-03 NCI60_001657 NSC-19987 NSC19987 Nirypan Noretona Predni N Tablinen Prednol- L Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI) Prestwick0_000279 Prestwick1_000279 Prestwick2_000279 Prestwick3_000279 Prestwick_622 Promacortine Reactenol S1733_Selleck SAM002589984 SMR000058330 SPBio_002377 Sieropresol Solomet Solu-medrol Summicort Suprametil U 7532 UNII-X4W7ZR7023 Urbason Urbasone Wyacort ZINC03875560 delta(1)-6alpha-Methylhydrocortisone delta(sup 1)-6-alpha-Methylhydrocortisone methylprednisolone methylprenisolone | |
| | 39 | | Methotrexate | approved | Phase 3, Phase 2, Phase 1 | 1444 | 1959-05-2, 59-05-2 | 126941 | 4-amino-10-methylfolic acid 4-amino-N(10)-Methylpteroylglutamic acid Abitrexate Amethopterin Amethopterine Antifolan Arbitrexate Emtexate Folex HDMTX L-Amethopterin Ledertrexate MTX Metatrexan Methopterin Methotextrate | Methotrate Methotrexat Methotrexate Methotrexate Sodium Methotrexatum Methylaminopterin Methylaminopterinum Metoject Metotrexato Mexate Méthotrexate N-Bismethylpteroylglutamic Acid N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid Otrexup Rasuvo Rheumatrex Rheumatrex Dose Pack Trexall |
| | 40 | | Vinblastine | approved | Phase 3, Phase 2 | 230 | 865-21-4 | 13342, 241903 | (2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE (2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine (2xi,3beta,4'beta,19xi)-vincaleukoblastine (3aR-(3aalpha,4beta,5beta,5abeta,9(3R*,5S*,7R*,9S*),10bR*,13aalpha))-methyl 4-(acetyloxy)-3a-ethyl-9-(5-ethyl-1,4,5,6,7,8,9,10-octahydro-5-hydroxy-9-(methoxycarbonyl)-2H-3,7-methanoazacycloundecino(5,4-b)indol-9-yl)-3a,4,5,5a,6,11,12,13a-octahydro-5-hydroxy-8-methoxy-6-methyl-1H-indolizino(8,1-cd)carbazole-5-carboxylate 143-67-9 1z2b 29060-LE 865-21-4 AC-20335 AC1L21JC AC1L68D2 AC1MXZJ2 BIDD:PXR0201 BRD-K01188359-065-02-5 BSPBio_001228 BSPBio_003594 Bio-0111 C07201 C46H58N4O9 CCRIS 9002 CHEBI:171516 CHEBI:27375 CHEMBL159 CHEMBL607706 CID13342 CID241903 CID3823887 CID6710780 D08675 DB00570 EINECS 212-734-0 HMS2090K05 HSDB 3263 KBio3_003033 LS-1859 LS-187263 | MolPort-002-518-262 MolPort-005-910-359 NCGC00022585-04 NCGC00181127-01 NCI-C04842 NCI60_004200 NChemBio.2007.10-comp22 NDC 0002-1452-01 NSC 47842 Neuro_000020 Nincaluicolflastine Rozevin SPBio_000680 STOCK1N-38480 Spectrum2_000890 Spectrum3_001994 UNII-5V9KLZ54CY VLB VR-8 Velban Velbe Vinblastin Vinblastina Vinblastina (TN) Vinblastina [DCIT] Vinblastina [Dcit] Vinblastine Vinblastine (INN) Vinblastine Sulfate Vinblastine [INN:BAN] Vinblastinum Vinblastinum [INN-Latin] Vincaleucoblastin Vincaleucoblastine Vincaleukoblastine Vincoblastine nchembio873-comp22 vinblastine |
| | 41 | | Prednisolone | approved | Phase 3, Phase 2, Phase 1 | 1082 | 50-24-8 | 5755 | (11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione .DELTA.1-Cortisol .DELTA.1-Dehydrocortisol .DELTA.1-Dehydrohydrocortisone .DELTA.1-Hydrocortisone .delta.-Cortef .delta.-Stab 1,2-Dehydrohydrocortisone 1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione 1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol 1-Dehydrocortisol 1-Dehydrohydrocortisone 3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene 46656_FLUKA 46656_RIEDEL 50-24-8 58201-11-9 8056-11-9 AC-1773 AC1L1L2E Ak-Pred Ak-Tate Alphadrol Articulose-50 BPBio1_000164 BRD-K98039984-001-03-0 BRN 1354103 BSPBio_000148 Bio-0666 Bubbli-Pred C07369 CCRIS 980 CHEBI:8378 CHEMBL131 CID5755 CO-Hydeltra CPD000718761 Co-Hydeltra Codelcortone Cordrol Cortalone Cotogesic Cotolone D00472 D011239 DB00860 Decaprednil Decortin H Delcortol Delta F Delta(1)-dehydrohydrocortisone Delta-Cortef Delta-Cortef (TN) Delta-Ef-Cortelan Delta-Stab Delta-stab Deltacortenol Deltacortril Deltacortril Enteric Deltahydrocortisone Deltasolone Deltisilone Depo-Medrol Derpo PD Derpo Pd Dexa-Cortidelt Hostacortin H Dexa-Cortidelt hostacortin H Di Adreson F Di-Adreson F Di-Adreson-F Di-adreson F DiAdresonF Dicortol Donisolone Dydeltrone EINECS 200-021-7 Eazolin D Econopred Econopred Plus Erbacort Erbasona Estilsona Fernisolone Fernisolone P Fernisolone-P Flamasone Flo-pred HMS1568H10 HMS2090J05 HSDB 3385 Hostacortin H Hydeltra Hydeltra-Tba Hydeltrasol Hydeltrone Hydrodeltalone Hydrodeltisone Hydroretrocortin Hydroretrocortine I-Pred Inflamase Forte Inflamase Mild K 1557 Key-Pred Klismacort LMST02030179 LS-7669 Lentosone Lite Pred M-Predrol MLS001304083 | MLS002154250 MLS002207037 Medrol Medrol Acetate Metacortandralone Methylprednisolone Acetate Meti-Derm Meticortelone Metreton Millipred MolPort-002-507-147 NCGC00179649-01 NSC 9120 NSC9120 NSC9900 Neo-Delta-Cortef Nisolone Nor-Pred T.B.A. Ocu-Pred Ocu-Pred Forte Omnipred Ophtho-Tate Orapred P0152_SIGMA P0637 P6004_SIGMA PRDL PRED-G Panafcortelone Paracortol Paracotol Pediapred Poly-Pred Precortalon Precortancyl Precortilon Precortisyl Pred Forte Pred Mild Predair Predair A Predair Forte Predalone 50 Predalone T.B.A. Predate Predate Tba Predate-50 Predcor-25 Predcor-50 Predcor-Tba Predisolone Sodium Phosphate Predne-Dome Prednelan Predni-Dome Prednicen Predniliderm Predniretard Prednis Prednisolona Prednisolona [INN-Spanish] Prednisolone Prednisolone (JP15/USP/INN) Prednisolone (anhydrous) Prednisolone Acetate Prednisolone Sodium Phosphate Prednisolone Tebutate Prednisolone [INN:BAN:JAN] Prednisolonum Prednisolonum [INN-Latin] Predonin Predonine Prelone Prenolone Prestwick0_000274 Prestwick1_000274 Prestwick2_000274 Prestwick3_000274 Prestwick_404 Rolisone S1737_Selleck SAM002264639 SMR000718761 SPBio_002367 Scherisolon Solone Steran Sterane Sterolone Supercortisol UNII-9PHQ9Y1OLM Ulacort Ultra Pred Ultracorten H Ultracortene H Ultracortene-H Ultracortene-Hydrogen Ultracortene-hydrogen ZINC03833821 component of Ataraxoid component of K-Predne-Dome delta(1)-Cortisol delta(1)-Dehydrocortisol delta(1)-Dehydrohydrocortisone delta(1)-Hydrocortisone delta(sup 1)-Cortisol delta(sup 1)-Dehydrocortisol delta(sup 1)-Dehydrohydrocortisone delta(sup 1)-Hydrocortisone delta-dehydrocortisol delta-dehydrohydrocortisone delta-hydrocortisone prednisolone | |
| | 42 | | Carmustine | approved | Phase 3, Phase 2, Phase 1 | 207 | 154-93-8 | 2578 | 1,3-BIS(CHLOROETHYL)-1-NITROSOUREA 1,3-Bis(.beta.-chloroethyl)-1-nitrosourea 1,3-Bis(2-chloroethyl)-1-nitrosourea 1,3-Bis(2-chloroethyl)nitrosourea 1,3-Bis(beta-chloroethyl)-1-nitrosourea 154-93-8 AC-10563 AC1L1DZQ AI3-52216 BCNU BCNU [Chloroethyl nitrosoureas] BRN 2049744 Becenum Becenun Bi CNU BiCNU BiCNU (TN) Bicnu Bicnu (tn) Bio-0118 Bis(2-chloroethyl)1-nitrosourea Bis(2-chloroethyl)nitrosourea Bis(chloroethyl)nitrosourea Bis-N,N'-(chloroethyl)nitrosourea Bischlorethylnitrosourea Bischlorethylnitrosurea Bischloroethyl nitrosourea Bischloroethyl nitrosourea [Chloroethyl nitrosoureas] Bischloroethylnitrosourea C 0400 C0400_SIGMA C5H11Cl2N3O2 CCRIS 810 CHEBI:3423 CHEMBL513 CID2578 Carmubris Carmustin Carmustina Carmustina [INN-Spanish] Carmustine Carmustine (USAN/INN) Carmustine [USAN:INN:BAN] Carmustinum Carmustinum [INN-Latin] D002330 D00254 DB00262 DTI 015 DivK1c_000835 EINECS 205-838-2 | EU-0100188 FDA 0345 FIVB FT-0083563 Gliadel Gliadel Wafer Gliadel, BCNU, NSC-409962, Becenun, Carmustine HMS2092J22 HMS502J17 I14-11976 IDI1_000835 KBio1_000835 KBio2_000745 KBio2_003313 KBio2_005881 KBioGR_001296 KBioSS_000745 LS-890 Lopac-C-0400 Lopac0_000188 MLS001333962 MolPort-003-665-505 N,N'-BIS(2-CHLOROETHYL)-N-NITROSOUREA N,N'-Bis(2-chloroethyl)-N-nitrosourea NCGC00015204-01 NCGC00015204-02 NCGC00015204-06 NCGC00093665-01 NCGC00093665-02 NCGC00093665-03 NCGC00093665-04 NCI-C04773 NCI60_003931 NINDS_000835 NSC 409962 NSC-409962 NSC409962 Nitrumon Prestwick_997 S1521_Selleck SK 27702 SMR000058426 SRI 1720 STK624770 Spectrum4_000888 Spectrum5_000920 Spectrum_000265 UNII-U68WG3173Y WLN: ONN2GVM2G ZINC03830387 bis-chloroethylnitrosourea carmustine carmustine in ethanol |
| | 43 | | Tacrolimus | approved, investigational | Phase 3, Phase 2, Phase 1 | 1023 | 104987-11-3 | 445643, 439492, 445647 | (-)-FK 506 (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone 104987-11-3 109581-93-3 (Hydrate) 15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone, 3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN 8-DEETHYL-8-[but-3-enyl]-ascomycin AC-1182 AC1L1K7H AC1L97GB AC1L9IBU AKOS005145901 Advagraf Ambap104987-11-3 Ambap5429 BCBcMAP01_000194 BRD-K35452788-001-02-1 BSPBio-001279 BSPBio_001279 Bio-0921 Bio2_000470 Bio2_000950 C01375 C44H69NO10 CCRIS 7124 CHEBI:100924 CHEBI:61049 CHEMBL1200738 CID11158639 CID11556866 CID439492 CID445643 CID5372 CID5472317 CID6426916 CID6436007 CID6473866 CID6536850 CID6610362 CID6912836 CID9832283 CID9853905 CID9918805 CID9940643 CID9963169 CPD-10016 CPD000466356 D08556 DB00864 DivK1c_001040 FK 506 FK-506 FK5 FK506 FR 900506 FR-900506 FR900506 | FT-0082660 Fk-506 Fujimycin Graceptor HMS1362O21 HMS1792O21 HMS1990O21 HMS2051C18 HMS2093M19 HMS503O21 Hecoria IDI1_001040 IDI1_002225 K506 KBio1_001040 KBio2_000619 KBio2_003187 KBio2_005755 KBio3_001097 KBio3_001098 KBioGR_000619 KBioSS_000619 L 679934 L-679934 LCP-Tacro LMPK04000003 LS-64247 MLS000759471 MLS001424054 Modigraf MolPort-003-666-518 NCGC00163470-01 NCGC00163470-02 NCGC00163470-03 NCGC00163470-04 NCGC00179232-01 NChemBio.2007.16-comp1 NINDS_001040 NSC717865 Prograf Prograf (TN) Protopic Protopy S5003_Selleck SAM001246677 SMR000466356 Tacarolimus Tacrolimus Tacrolimus (INN) Tacrolimus (Prograf?) Tacrolimus (anhydrous) Tacrolimus Hydrate Tacrolimus anhydrous Tacrolimus hydrate Tsukubaenolide UNII-Y5L2157C4J nchembio.2007.23-comp2 tacrolimus tacrolimus hydrate | |
| | 44 | | Cisplatin | approved | Phase 3, Phase 2, Phase 1 | 2540 | 15663-27-1 | 84093, 441203, 2767 | (SP-4-1)-diamminedichloridoplatinum (SP-4-1)-diamminedichloroplatinum (SP-4-2)-diamminedichloridoplatinum (SP-4-2)-diamminedichloroplatinum Abiplatin Biocisplatinum Briplatin CACP CDDP CHEBI:35852 CID441203 CPD0-1392 CPDC CPDD Carboquone Cis Pt II Cis-DDP Cis-Diaminedichloroplatinum Cis-Diamminedichloroplatinum Cismaplat Cisplatin Cisplatine Cisplatino Cisplatinum Cisplatyl Citoplationo DB00515 DDP DDPT Diamminedichloroplatinum | EU-0100918 Lederplatin Neoplatin Peyrone's chloride Peyrone's salt Plastin Platamine Platiblastin Platidiam Platinex Platinol Platinol-AQ Platinol-aq Platinoxan Platinum Ammine Chloride Platinum Ammonium Chloride Platinum Diamine Dichloride Randa Trans-DDP Trans-Diaminedichloroplatinum Trans-Diamminedichloroplatinum Trans-Dichlorodiammine Platinum Trans-Platinumdiammine Dichloride cis-DDP cis-Diamminedichloroplatinum cis-Dichlorodiammineplatinum(II) cis-[PtCl2(NH3)2] cis-diamminedichloridoplatinum(II) cis-diamminedichloroplatinum(II) nchembio773-comp1 trans-diamminedichloridoplatinum(II) | |
| | 45 | | Lenalidomide | approved | Phase 3, Phase 1, Phase 2 | 674 | 191732-72-6 | 216326 | 1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline 191732-72-6 3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione 3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione 3-(7-Amino-3-oxo-1H-isoindol-2-yl)-piperidine-2,6-dione 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione 346670-73-3 443912-14-9 AC-914 AC1L50II AKOS005146276 ALBB-015321 Bio-0168 C467567 CC 5013 CC-5013 CC-5013, Revlimid, Lenalidomide CC5013 CDC 501 CDC-501 CDC-5013 CHEMBL848 CID216326 Celgene brand of lenalidomide D04687 | DB00480 EC-000.2340 ENMD-0997 I06-0831 IMID-1 IMID-5013 IMiD3 IMiD3 cpd IMid-1 LS-184040 Lenalidomide Lenalidomide (USAN/INN) Lenalidomide [USAN] MolPort-003-848-370 NCGC00167491-01 NSC747972 Revamid Revimid Revlimid Revlimid (Celgene) Revlimid (TN) S1029_Selleck STK639603 Thalidomide analog CC-5013 UNII-F0P408N6V4 lenalidomide | |
| | 46 | | Cytarabine | approved, investigational | Phase 3, Phase 2, Phase 1, Phase 0 | 1035 | 147-94-4 | 6253 | (beta-D-Arabinofuranosyl)cytosine (beta-D-arabinofuranosyl)cytosine 1-.beta.-D-arabinofuranosyl-cytosine 1-Arabinofuranosylcytosine 1-beta -D-Arabinofaranosylcytosine 1-beta -D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone 1-beta -D-Arabinofuranosylcytosine 1-beta-D-Arabinofaranosylcytosine 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone 1-beta-D-Arabinofuranosyl-Cytosine 1-beta-D-Arabinofuranosylcytosine 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside 1-beta-D-Arabinosyl-Cytosine 1-beta-D-Arabinosylcytosine 147-94-4 1beta -Arabinofuranasylcytosine 1beta -D-Arabinofuranosylcytosine 1beta -D-Arabinosylcytosine 1beta-Arabinofuranasylcytosine 1beta-D-Arabinofuranosylcytosine 1beta-D-Arabinosylcytosine 2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl- [CAS] 2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl 30399_FLUKA 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech] 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech] 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one 69-74-9 (hydrochloride) AC-1075 AC1L1M4F AC1Q52OJ AI3-52329 AR3 Alexan Ara-C Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine Ara-Cytidine AraC Arabinocytidine Arabinofuranosyl Cytidine Arabinofuranosylcytosine Arabinosyl Cytosine Arabinosylcytosine Arabitin Aracytidine Aracytin Aracytine Arafcyt BIDD:GT0371 BIDD:PXR0139 BTB15125 Beta-cytosine arabinoside C02961 C1768_SIGMA C2035 C9H13N3O5 CCRIS 913 CHEBI:28680 CHEMBL803 CHX 3311 CID6253 CPD000449317 CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9) Citarabina Citarabina [INN-Spanish] Cytarabin Cytarabina Cytarabine Cytarabine (JP15/USP/INN) | Cytarabine [USAN:INN:BAN:JAN] Cytarabine liposome injection Cytarabinoside Cytarabinum Cytarabinum [INN-Latin] Cytarbel Cytonal Cytosar Cytosar-U Cytosine 1-beta-D-arabinofuranoside Cytosine arabinofuranoside Cytosine arabinose Cytosine arabinoside Cytosine arabinoside (VAN) Cytosine beta-D-arabinofuranoside Cytosine beta-D-arabinofuranoside hydrochloride Cytosine beta-D-arabinoside Cytosine, beta -D-arabinoside Cytosine, beta-D-arabinoside Cytosine-1-beta-D-arabinofuranoside Cytosine-1-beta-D-arabinofuranoside hydrochloride Cytosine-beta -D-arabinofuranoside Cytosine-beta -arabinoside Cytosine-beta-D-arabinofuranoside Cytosine-beta-arabinoside Cytosinearabinoside D00168 DB00987 DepoCyte Depocyt Depocyt (TN) Depocyt (liposomal) Depocyte EINECS 205-705-9 Erpalfa FT-0082880 HMS2051K19 HMS2090A18 HSDB 3049 Intrathecal (injected into the spinal fluid) DepoCyt Intrathecal cytarabine (also known as ara-C) Iretin LS-860 Lopac0_000316 MLS000758310 MLS001066340 MolPort-001-792-509 NCGC00093356-03 NCGC00093356-04 NCGC00093356-05 NCI-C04728 NSC 287459 NSC287459 S1648_Selleck SAM001247012 SMR000449317 SR-01000075773-3 Spongocytidine TL8001048 Tarabine U 19920A U-19,920 U-19920 UNII-04079A1RDZ Udicil ZINC03795098 beta -D-arabinosylcytosine beta -arabinosylcytosine beta -cytosine arabinoside beta-Ara C beta-Ara c beta-Arabinosylcytosine beta-Cytosine arabinoside beta-D-Arabinosylcytosine cytarabine cytarabine liposome injection cytosine-β-D-arabinofuranoside |
| | 47 | | Bortezomib | approved, investigational, experimental | Phase 3, Phase 2, Phase 1, Phase 0 | 769 | 179324-69-7 | 387447, 93860 | 179324-69-7 AC1L8TUW Bortezomib Bortezomib (JAN/USAN/INN) CHEBI:287372 CHEBI:41143 CHEMBL325041 CID387447 D03150 DB07475 DPBA FT-0082488 I14-3268 LDP-341 LDP341 LPD 341 LPD-341 | MLN341 MolPort-003-845-298 N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE N-[(1R)-1-(DIHYDROXYBORYL)-3-methylbutyl]-N-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide NCI60_029010 NSC-681239 NSC681239 PROSCRIPT BORONIC ACID PS 341 PS-341 Pyz-Phe-boroLeu S1013_Selleck SBB071337 Velcade Velcade (TN) Velcade, MG-341, PS-341, Bortezomib [(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid bortezomib |
| | 48 | | Benzocaine | approved | Phase 3, Phase 2, Phase 1 | 1684 | 1994-09-7, 94-09-7 | 2337 | (p-(Ethoxycarbonyl)phenylamine 06952_FLUKA 112909_ALDRICH 112909_SIAL 1333-08-0 20/20 Topical Anesthetic 23239-88-5 23239-88-5 (hydrochloride) 4 Aminobenzoic Acid Ethyl Ester 4-(Ethoxycarbonyl)aniline 4-(Ethoxycarbonyl)phenylamine 4-14-00-01129 (Beilstein Handbook Reference) 4-Aminobenzoate 4-Aminobenzoic acid 4-Aminobenzoic acid ethyl ester 4-Aminobenzoic acid, ethyl ester 4-Carbethoxyaniline 4-amino-benzoic acid ethyl ester 4-aminobenzoic acid ethyl ester 71123-91-6 94-09-7 94-09-7 (Parent) A0271 AB00051923 AC1L1DGC AC1Q341A AC1Q64JE AE-562/40377256 AI3-02081 AKOS000119763 AR-1H9065 Acetate, Benzocaine Aethoform Aethylium paraminobenzoicum Alcohol Prep Pads Allegenal-m Alpha-caine Topical Anesthetic Amben ethyl ester Americaine Anaesthan-syngala Anaesthesin Anaesthesinum Anaesthin Anbesol Jr Anbesol Maximum Strength Anbesol Regular Strength Anestenka Anestezin Anestezin [Russian] Anesthesin Anesthesine Anesthetic Anesthone Atopalm Oral Pain Relief BB_SC-0019 BPBio1_001017 BRD-K75466013-001-05-2 BRN 0638434 BSPBio_000923 BSPBio_001908 Baby Anbesol Baby Anestenka Baby Sensigel Baby Sensigel Night Time Formula Baby Teething Oral Pain Reliever Bactimicina For Sore Throat Bencocaine Topical Anesthetic Bensokain Benz O Sthetic Benzoak Benzocaina Benzocaina [INN-Spanish] Benzocaine Benzocaine (USP/INN) Benzocaine Acetate Benzocaine Formate Benzocaine Hydrobromide Benzocaine Hydrochloride Benzocaine Methanesulfonate Benzocaine [INN:BAN] Benzocainum Benzocainum [INN-Latin] Benzodent Benzoic acid, 4-amino-, ethyl ester Benzoic acid, 4-amino-, ethyl ester, hydrochloride Benzoic acid, amino-, ethyl ester Benzoic acid, p-amino-, ethyl ester Boil Ease Boy Butter Desensitizing Lubricant Boy Butter Extreme Desensitizing Lubricant Boy Butter Extreme H2O Desensitizing Lubricant Brace Relief Budpak Baby Teething Oral Pain Reliever Budpak Oral Maximum Strength C07527 CAS-94-09-7 CHEBI:116735 CHEMBL278172 CID2337 Carmex Cold Sore Treatment External Analgesic Caswell No. 430A Cepacol Fizzlers Cepacol Sensations Hydra Cepacol Sensations Sore Throat Hydra citrus splash Cepacol Sensations Warming Certus Sting Relief Prep Pad Chloraseptic Chloraseptic Warming Sore Throat Colgate Orabase Comfortcaine Topical Anesthetic Cvs Fast Acting Baby Teething Cvs Maximum Strength Cvs Maximum Strength Boil Relief Cvs Oral Anesthetic Cvs Pharmacy Instant Toothache Cvs Pharmacy Maximum Strength Cvs Pharmacy Mouth Sore Gel Cvs Pharmacy Nighttime Oral Pain Relief D001566 D00552 DB01086 Dental Relief Dentek Instant Pain Relief Maximum Strength Dermoplast Diet Ayds DivK1c_000932 Dollar General Toothache Relief Dukal Sting Relief Pad E1501_SIGMA EINECS 202-303-5 EPA Pesticide Chemical Code 097001 ETHYL-P-AMINOBENZOATE Ethoform Ethoforme Ethyl 4-aminobenzoate Ethyl 4-aminobenzoate hydrochloride Ethyl 4-aminobenzoic acid Ethyl Aminobenzoate Ethyl PABA Ethyl aminobenzoate Ethyl aminobenzoate (JP15) Ethyl aminobenzoate (VAN) Ethyl aminobenzoic acid Ethyl p-Aminobenzoate Ethyl p-Aminophenylcarboxylate Ethyl p-aminobenzenecarboxylate Ethyl p-aminobenzoate Ethyl p-aminobenzoic acid Ethyl p-aminophenylcarboxylate Ethylester kyseliny p-aminobenzoove Ethylester kyseliny p-aminobenzoove [Czech] Ethylis aminobenzoas Finafta Baby Finafta MultiOral Formate, Benzocaine Gelato Topical Anesthetic Good Neighbor Pain Relief Goodsense Oral Pain Relief Gps Topical Anesthetic Gumnumb Topical Anesthetic HMS1570O05 HMS1920G09 HMS2091M11 HMS502O14 HSDB 7225 Heb Severe Toothache Herbasoul Male Genital Desensitizer Cream | Hurricaine Hurricaine Topical Anesthetic Hurricaine Topical Anesthetic Gel Hurricaine Topical Anesthetic Liquid Hydrobromide, Benzocaine Hydrochloride, Benzocaine I05-0204 IDI1_000932 Identhesin Insect Bite Relief Instant Toothache Pain Relief Intense Cvs Intense Toothache Iodent Maximum Strength Oral Analgesic Ismile Topical Anesthetic Jianze Sting Relief Pads KBio1_000932 KBio2_000474 KBio2_003042 KBio2_005610 KBio3_001408 KBioGR_000658 KBioSS_000474 Kank-a Mouth Pain Keloform Kmart Smart Sense Kroger Toothache Pain Relief LS-35847 Leader Oral Analgesic Little Colds Sore Throat Relief Melt Aways MLS001331704 MLS002153970 Makesense Junior Pain Relief Makesense Pain Relief Male Desensitizer Pleasure Balm Mandelay Male Genital Desensitizer Mark 3 Methanesulfonate, Benzocaine MolPort-000-871-526 Mouth Sore Medication Mouth Sore Relief Applicator Mouth Sore Relief Professional Strength My Fair Baby Instant Pain Relief NCGC00016352-01 NCGC00094598-01 NCGC00094598-02 NINDS_000932 NSC 122792 NSC 41531 NSC41531 NSC4688 Nene Dente Norcain Norcaine Norcainum Opahl Opahl Dye Free Oprea1_750694 Oprea1_827402 Ora-jel Orabase-B Orajel For All Mouth Sores Maximum Strength Orajel For Cold Sores Orajel For Toothache Maximum Strength Orajel Instant Pain Relief Maximum Strength Orajel Instant Pain Relief Regular Strength Orajel Instant Relief For Teething Pain Orajel Instant Relief For Teething Pain Cooling Cucumber Orajel Instant Relief For Teething Pain Daytime Nighttime Twin Pack Orajel Instant Relief For Teething Pain Longer Lasting Orajel Maximum Strength Orajel Nighttime Instant Relief For Teething Pain Longer Lasting Extra Strength Orajel Severe Toothache Maximum Strength Fast-Acting Formula Oral Analgesic Maximum Strength Oral B Instant Pain Relief Oral Gel Maximum Strength Oral Pain Relief Anesthetic Anesthetic Oral Pain Reliever Oralabs Cold Sore Treatment Orthesin Otocain Outgro Pac-dent Top Gel Pain Relief Pain Relief Alcohol Swabs Parathesin Parathesin (TN) Parathesine Physicians Care Sting Relief Pad Pleasure Balm Kama Sutra Preboost Prestwick0_000712 Prestwick1_000712 Prestwick2_000712 Prestwick3_000712 Prestwick_991 Purelife Topical Anesthetic Quality Choice Maximum Strength Oral Pain Relieving Red Cross Oral Pain Relief Rexall Maximum Strength Rite Aid Baby Care Rite Aid Liquid Anesthetic Oral Pain Relief Rite Aid Maximum Strength Rite Aid Oral Pain Reliever Rite Aid Professional Strength SMR000059025 SPBio_000134 SPBio_002844 SPECTRUM1500139 STK043620 Sally Hansen Ouch-relief Numbing Wipes Sally Hansen Ouch-relief Wax Kit Sally Hansen Ouch-relief Wax Strip Kit Sensigel Severe Oral Pain Reliever Sheffield Baby Teething Gel Sheffield Pain Relief Shunga Male Genital Desensitizer Slim Mint Gum Solarcaine Solu H Spectrum2_000117 Spectrum3_000314 Spectrum4_000249 Spectrum5_000860 Spectrum_000074 Sting Relief Medicated Pad Sting Relief Pads Tanac Terrasil Boil Pain Relief Tiger Supply Inc Topical Anesthetic Top Quality Mfg. Topical Anesthetic Topcaine Topcare Maximum Strength Topical Anesthetic Banana Topical Anesthetic Bubble Gum Topical Anesthetic Cherry Topical Anesthetic Mint Topical Anesthetic Pina Colada Topical Anesthetic Raspberry Topical Anesthetic Strawberry UNII-U3RSY48JW5 Ultracare Anesthetic Bubble Gum Ultracare Anesthetic Butter Rum Ultracare Anesthetic Creme de Menthe Ultracare Anesthetic Pina Colada Ultracare Anesthetic Walterberry WLN: ZR DVO2 Walgreens Baby Teething Walgreens Intense Toothache Walgreens Maximum Strength Walgreens Pain Relieving For Boils Walgreens Severe Oral Pain Reliever Walgreens Severe Toothache Relief Winco Foods Maximum Strength Oral Analgesic ZINC12358719 Zilactin-b benzocaine ethylaminobenzoate-4 h-4-abz-oet nchembio.182-comp4 p-(Ethoxycarbonyl)aniline p-Aminobenzoate p-Aminobenzoic acid p-Aminobenzoic acid ethyl ester p-Aminobenzoic acid, ethyl ester p-Aminobenzoic ethyl ester p-Carbethoxyaniline p-Ethoxycarboxylic Aniline p-Ethoxycarboxylic aniline |
| | 49 | | Mycophenolic acid | approved | Phase 3, Phase 2, Phase 1 | 898 | 24280-93-1 | 446541 | (e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid Acide mycophenolique Acido micofenolico Acidum mycophenolicum Melbex | Micofenolico acido Mycophenoic acid Mycophenolate Mycophenolic Acid Mycophenolsaeure Myfortic | |
| | 50 | | Piperacillin | approved | Phase 3 | 86 | 66258-76-2 | 43672 | (2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (2S-(2alpha,5alpha,6beta(S*)))-6-(((((4-Ethyl-2,3-dioxopiperazin-1-yl)carbonyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid 4-ethyl-2,3-dioxopiperazine carbonyl ampicillin 59703-84-3 59703-84-3 (mono-hydrochloride salt) 6-(D-(-)-alpha-(4-Ethyl-2,3-dioxo-1-piperazinecarboxamido)phenylacetamido)penicillanic acid 61477-96-1 6beta-{(2R)-2-[(4-ethyl-2,3-dioxopiperazin-1-yl)carboxamido]-2-phenylacetamido}-2,2-dimethylpenam-3alpha-carboxylic acid AC1L2ACR AC1Q5QXJ BIDD:GT0167 BPBio1_000848 BRD-K86873305-236-03-0 BSPBio_000770 C14034 C23H27N5O7S CCRIS 7362 CHEBI:8232 CHEMBL702 CID43672 Cl-227193 D08380 EINECS 262-811-8 HMS2090H19 LS-149794 | PIPC PIPERACILLIN SODIUM Peperacillin Peracin Peracin (TN) Piperacilina Piperacillin Piperacillin (INN) Piperacillin (anhydrous) Piperacillin Anhydrous Piperacillin Monosodium Salt Piperacillin Sodium Piperacillin anhydrous Piperacillina Piperacillinum Pipercillin Pipracil Pipracil, Piper Pipril Pipéracilline Prestwick0_000755 Prestwick1_000755 Prestwick2_000755 Prestwick3_000755 SPBio_002709 T-1220 UNII-9I628532GX piperacillin |
|
Interventional clinical trials: (show top 50)
(show all 891)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | Bone Marrow Transplantation in Treating Patients With Hematologic Cancer | Completed | NCT00003398 | Phase 4 | | 2 | Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma | Recruiting | NCT01180049 | Phase 4 | | 3 | An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma | Active, not recruiting | NCT01833039 | Phase 4 | | 4 | Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma | Completed | NCT00003280 | Phase 3 | | 5 | Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) | Completed | NCT01073163 | Phase 3 | | 6 | Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL) | Completed | NCT00117598 | Phase 3 | | 7 | Bendamustine Plus Rituximab Versus Fludarabine Plus Rituximab | Completed | NCT01456351 | Phase 3 | | 8 | Mantel Cell Lymphoma Efficacy of Rituximab Maintenance | Completed | NCT00921414 | Phase 3 | | 9 | Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications | Completed | NCT00799461 | Phase 3 | | 10 | Bendamustine Plus Rituximab Versus CHOP Plus Rituximab | Completed | NCT00991211 | Phase 3 | | 11 | A Study of MabThera (Rituximab) in Patients With Advanced Non-Hodgkin's Lymphoma | Completed | NCT00269113 | Phase 3 | | 12 | Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma | Completed | NCT00005590 | Phase 3 | | 13 | Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy | Completed | NCT00003341 | Phase 3 | | 14 | Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma | Completed | NCT00278408 | Phase 3 | | 15 | Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count | Completed | NCT00003805 | Phase 3 | | 16 | St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer | Completed | NCT00005805 | Phase 3 | | 17 | Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter | Completed | NCT00006083 | Phase 3 | | 18 | Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer | Completed | NCT00661999 | Phase 3 | | 19 | Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer | Completed | NCT00070382 | Phase 3 | | 20 | American Ginseng in Treating Patients With Fatigue Caused by Cancer | Completed | NCT00719563 | Phase 3 | | 21 | Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial | Completed | NCT00750009 | Phase 3 | | 22 | Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain | Completed | NCT00666211 | Phase 3 | | 23 | Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment | Completed | NCT00008359 | Phase 3 | | 24 | Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients | Completed | NCT00003938 | Phase 3 | | 25 | Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain | Completed | NCT00538850 | Phase 3 | | 26 | Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer | Completed | NCT00265837 | Phase 3 | | 27 | Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant | Completed | NCT00305851 | Phase 3 | | 28 | Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation | Completed | NCT00014391 | Phase 3 | | 29 | Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation | Completed | NCT00004230 | Phase 3 | | 30 | Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation | Completed | NCT00003883 | Phase 3 | | 31 | Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation | Completed | NCT00045292 | Phase 3 | | 32 | Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma | Completed | NCT00004112 | Phase 3 | | 33 | Treatment for Chronic Pain in Patients With Advanced Cancer | Completed | NCT00003687 | Phase 3 | | 34 | Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases | Completed | NCT00438958 | Phase 3 | | 35 | Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer | Completed | NCT00053053 | Phase 3 | | 36 | Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment | Completed | NCT00006348 | Phase 3 | | 37 | Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease | Completed | NCT00003414 | Phase 3 | | 38 | Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL | Recruiting | NCT00209209 | Phase 3 | | 39 | STUDY WITH LENALIDOMIDE (Revlimid®) MAINTENANCE VS OBSERVATION AFTER INTENSIFIED INDUCTION REGIMEN CONTAINING RITUXIMAB FOLLOWED BY HIGH DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION AS FIRST LINE TREATMENT IN ADULT PATIENTS WITH ADVANCED MAN | Recruiting | NCT02354313 | Phase 3 | | 40 | Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma. | Recruiting | NCT01996865 | Phase 3 | | 41 | Fludarabine and Cyclophosphamide With or Without Rituximab in Treating Patients With Previously Untreated Mantle Cell Lymphoma | Recruiting | NCT00641095 | Phase 3 | | 42 | Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL | Recruiting | NCT00209222 | Phase 3 | | 43 | Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas | Recruiting | NCT00877214 | Phase 3 | | 44 | R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL | Recruiting | NCT01865110 | Phase 3 | | 45 | Efficacy and Safety of R-HAD Alone or in Combination With Bortezomib in Patients With Relapsed or Refractory MCL | Recruiting | NCT01449344 | Phase 3 | | 46 | Double Cord Versus Haploidentical (BMT CTN 1101) | Recruiting | NCT01597778 | Phase 3 | | 47 | Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant | Recruiting | NCT01231412 | Phase 3 | | 48 | Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma | Recruiting | NCT00278421 | Phase 3 | | 49 | Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia | Recruiting | NCT00445497 | Phase 3 | | 50 | Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain | Recruiting | NCT01316744 | Phase 3 |
Cell-based therapeutics:Data from LifeMap, the Embryonic Development and Stem Cells Database Stem-cell-based therapeutic approaches for Mantle Cell Lymphoma: Embryonic/Adult Cultured Cells Related to Mantle Cell Lymphoma:
|
